{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:09:58Z","timestamp":1788977398532,"version":"build-2803163510"},"reference-count":256,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03531-2","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:47:11Z","timestamp":1788976031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanosuspension-based Ocular Therapeutics for Infection Control: Integrating Mucin Interactions and Tear Film Dynamics"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8398-4276","authenticated-orcid":false,"given":"Deepanjan","family":"Datta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7847-2846","authenticated-orcid":false,"given":"Maria","family":"Nison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5089-5975","authenticated-orcid":false,"given":"Viola","family":"Colaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5086-9447","authenticated-orcid":false,"given":"Vandana","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5252-336X","authenticated-orcid":false,"given":"Sony Priyanka","family":"Bandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-2653","authenticated-orcid":false,"given":"Namdev","family":"Dhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-4206","authenticated-orcid":false,"given":"Swati","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-6389","authenticated-orcid":false,"given":"Vasudev R","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"3531_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124192","volume":"658","author":"D Datta","year":"2024","unstructured":"Datta D, Priyanka Bandi S, Colaco V, Dhas N, Siva Reddy D, Vora LK. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics. International Journal of Pharmaceutics. 2024;658:124192. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124192.","journal-title":"International Journal of Pharmaceutics."},{"key":"3531_CR2","doi-asserted-by":"publisher","unstructured":"Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, et al. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels. Multidisciplinary Digital Publishing Institute; 2022;8:82. https:\/\/doi.org\/10.3390\/gels8020082","DOI":"10.3390\/gels8020082"},{"key":"3531_CR3","doi-asserted-by":"publisher","unstructured":"Kaushal U, Kaur M, Nagpal M, Bhuyan M, Gounder KP. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives. Current Drug Research Reviews. Bentham Science Publishers; 2023;15:15\u201328. https:\/\/doi.org\/10.2174\/2589977514666220913120718","DOI":"10.2174\/2589977514666220913120718"},{"key":"3531_CR4","doi-asserted-by":"publisher","unstructured":"Tan JYB, Yoon BK, Cho N-J, Lovri\u0107 J, Jug M, Jackman JA. Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides. International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute; 2021;22:9664. https:\/\/doi.org\/10.3390\/ijms22189664","DOI":"10.3390\/ijms22189664"},{"key":"3531_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/978-1-59745-375-2_21","volume-title":"Ocular transporters in ophthalmic diseases and drug delivery: ophthalmology research","author":"S Gunda","year":"2008","unstructured":"Gunda S, Hariharan S, Mandava N, Mitra AK. Barriers in ocular drug delivery. In: Tombran-Tink J, Barnstable CJ, editors. Ocular transporters in ophthalmic diseases and drug delivery: ophthalmology research. Totowa, NJ: Humana Press; 2008. p. 399\u2013413. https:\/\/doi.org\/10.1007\/978-1-59745-375-2_21."},{"key":"3531_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1463-5224.2004.00325.x","volume":"7","author":"HJ Davidson","year":"2004","unstructured":"Davidson HJ, Kuonen VJ. The tear film and ocular mucins. Vet Ophthalmol. 2004;7:71\u20137. https:\/\/doi.org\/10.1111\/j.1463-5224.2004.00325.x.","journal-title":"Vet Ophthalmol."},{"key":"3531_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2019.07.037","volume":"309","author":"RV Pai","year":"2019","unstructured":"Pai RV, Monpara JD, Vavia PR. Exploring molecular dynamics simulation to predict binding with ocular mucin: An in silico approach for screening mucoadhesive materials for ocular retentive delivery systems. J Control Release. 2019;309:190\u2013202. https:\/\/doi.org\/10.1016\/j.jconrel.2019.07.037.","journal-title":"J Control Release."},{"key":"3531_CR8","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.3390\/ijms20246132","volume":"20","author":"GA Georgiev","year":"2019","unstructured":"Georgiev GA, Eftimov P, Yokoi N. Contribution of Mucins towards the Physical Properties of the Tear Film: A Modern Update. Int J Mol Sci. 2019;20:6132. https:\/\/doi.org\/10.3390\/ijms20246132.","journal-title":"Int J Mol Sci."},{"key":"3531_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03390-0","volume":"24","author":"A Abusharha","year":"2024","unstructured":"Abusharha A, Pearce EI, Afsar T, Razak S. Evaluation of therapeutic efficacy of Emustil drops for ocular discomfort and tear film osmolarity using different treatment management modes under dry environmental conditions. BMC Ophthalmol. 2024;24:129. https:\/\/doi.org\/10.1186\/s12886-024-03390-0.","journal-title":"BMC Ophthalmol"},{"key":"3531_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02365-3","volume":"22","author":"J Lee","year":"2022","unstructured":"Lee J, Hwang G, Ha M, Kim H-S, Han K, Na K-S. Evaluation of the meibomian glands using the tear interferometer wearing orthokeratology lenses. BMC Ophthalmol. 2022;22:133. https:\/\/doi.org\/10.1186\/s12886-022-02365-3.","journal-title":"BMC Ophthalmol"},{"key":"3531_CR11","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1038\/s41433-023-02557-1","volume":"37","author":"M Yazdani","year":"2023","unstructured":"Yazdani M. Tear film lipid layer and corneal oxygenation: a new function? Eye (Lond). 2023;37:3534\u201341. https:\/\/doi.org\/10.1038\/s41433-023-02557-1.","journal-title":"Eye (Lond)"},{"key":"3531_CR12","doi-asserted-by":"publisher","unstructured":"Esam S, Singh S, Konda N, Gandhi R, Vemuganti GK. Tear Film Lipid Layer Thickness: Measurement Techniques, Normative Values and Alteration in Ocular Surface Diseases. Current Eye Research. Taylor & Francis; 0:1\u201315. https:\/\/doi.org\/10.1080\/02713683.2025.2458735","DOI":"10.1080\/02713683.2025.2458735"},{"key":"3531_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.preteyeres.2012.10.004","volume":"32","author":"TF Freddo","year":"2013","unstructured":"Freddo TF. A contemporary concept of the blood\u2013aqueous barrier. Prog Retin Eye Res. 2013;32:181\u201395. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.10.004.","journal-title":"Prog Retin Eye Res"},{"key":"3531_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101245","volume":"99","author":"O Tomkins-Netzer","year":"2024","unstructured":"Tomkins-Netzer O, Niederer R, Greenwood J, Fabian ID, Serlin Y, Friedman A, et al. Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy. Prog Retin Eye Res. 2024;99:101245. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101245.","journal-title":"Prog Retin Eye Res"},{"key":"3531_CR15","doi-asserted-by":"publisher","unstructured":"Das S, Suresh PK. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomedicine: Nanotechnology, Biology and Medicine. 2011;7:242\u20137. https:\/\/doi.org\/10.1016\/j.nano.2010.07.003","DOI":"10.1016\/j.nano.2010.07.003"},{"key":"3531_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ejps.2013.07.002","volume":"50","author":"C Luschmann","year":"2013","unstructured":"Luschmann C, Tessmar J, Schoeberl S, Strauss O, Framme C, Luschmann K, et al. Developing an in situ nanosuspension: A novel approach towards the efficient administration of poorly soluble drugs at the anterior eye. European Journal of Pharmaceutical Sciences. 2013;50:385\u201392. https:\/\/doi.org\/10.1016\/j.ejps.2013.07.002.","journal-title":"European Journal of Pharmaceutical Sciences."},{"key":"3531_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11671-008-9234-1","volume":"4","author":"P-C Chiang","year":"2009","unstructured":"Chiang P-C, Alsup JW, Lai Y, Hu Y, Heyde BR, Tung D. Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery. Nanoscale Res Lett. 2009;4:254. https:\/\/doi.org\/10.1007\/s11671-008-9234-1.","journal-title":"Nanoscale Res Lett."},{"key":"3531_CR18","doi-asserted-by":"publisher","unstructured":"Elmowafy M, Shalaby K, Al-Sanea MM, Hendawy OM, Salama A, Ibrahim MF, et al. Influence of Stabilizer on the Development of Luteolin Nanosuspension for Cutaneous Delivery: An In Vitro and In Vivo Evaluation. Pharmaceutics. Multidisciplinary Digital Publishing Institute; 2021;13:1812. https:\/\/doi.org\/10.3390\/pharmaceutics13111812","DOI":"10.3390\/pharmaceutics13111812"},{"key":"3531_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2147\/IJN.S447429","volume":"19","author":"MME Aldeeb","year":"2024","unstructured":"Aldeeb MME, Wilar G, Suhandi C, Elamin KM, Wathoni N. Nanosuspension-based drug delivery systems for topical applications. Int J Nanomedicine. 2024;19:825\u201344. https:\/\/doi.org\/10.2147\/IJN.S447429.","journal-title":"Int J Nanomedicine"},{"key":"3531_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104975","volume":"88","author":"P Suriyaamporn","year":"2023","unstructured":"Suriyaamporn P, Pornpitchanarong C, Pamornpathomkul B, Patrojanasophon P, Rojanarata T, Opanasopit P, et al. Ganciclovir nanosuspension-loaded detachable microneedles patch for enhanced drug delivery to posterior eye segment. Journal of Drug Delivery Science and Technology. 2023;88:104975. https:\/\/doi.org\/10.1016\/j.jddst.2023.104975.","journal-title":"Journal of Drug Delivery Science and Technology."},{"key":"3531_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124614","volume":"664","author":"HS Faizi","year":"2024","unstructured":"Faizi HS, Nasiri MI, Wu Y, Mishra D, Donnelly RF, Minhas MU, et al. Deferasirox nanosuspension loaded dissolving microneedles for ocular drug delivery. International Journal of Pharmaceutics. 2024;664:124614. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124614.","journal-title":"International Journal of Pharmaceutics."},{"key":"3531_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.212767","volume":"137","author":"Y Wu","year":"2022","unstructured":"Wu Y, Vora LK, Mishra D, Adrianto MF, Gade S, Paredes AJ, et al. Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye. Biomaterials Advances. 2022;137:212767. https:\/\/doi.org\/10.1016\/j.bioadv.2022.212767.","journal-title":"Biomaterials Advances."},{"key":"3531_CR23","doi-asserted-by":"publisher","unstructured":"Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. J Nanobiotechnol [Internet]. 2022 [cited 2026 Mar 16];20:262. https:\/\/doi.org\/10.1186\/s12951-022-01477-8","DOI":"10.1186\/s12951-022-01477-8"},{"key":"3531_CR24","doi-asserted-by":"publisher","unstructured":"Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res [Internet]. 2020 [cited 2026 Mar 16];24:3. https:\/\/doi.org\/10.1186\/s40824-020-0184-8","DOI":"10.1186\/s40824-020-0184-8"},{"key":"3531_CR25","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/pharmaceutics15051520","volume":"15","author":"SG P\u0131nar","year":"2023","unstructured":"P\u0131nar SG, Oktay AN, Karak\u00fc\u00e7\u00fck AE, \u00c7elebi N. Formulation Strategies of Nanosuspensions for Various Administration Routes. Pharmaceutics. 2023;15:1520. https:\/\/doi.org\/10.3390\/pharmaceutics15051520.","journal-title":"Pharmaceutics."},{"key":"3531_CR26","doi-asserted-by":"publisher","unstructured":"Liu Y, Liang Y, Yuhong J, Xin P, Han JL, Du Y, et al. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs. Drug Des Devel Ther [Internet]. 2024 [cited 2026 Mar 16];18:1469\u201395. https:\/\/doi.org\/10.2147\/DDDT.S447496","DOI":"10.2147\/DDDT.S447496"},{"key":"3531_CR27","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s H, Hern\u00e1ndez-Parra H, Bernal-Ch\u00e1vez SA, Prado-Audelo MLD, Caballero-Flor\u00e1n IH, Borbolla-Jim\u00e9nez FV, et al. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses. Materials (Basel). Basel, Switzerland; 2021;14:3197. https:\/\/doi.org\/10.3390\/ma14123197","DOI":"10.3390\/ma14123197"},{"key":"3531_CR28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","volume":"172","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172:1126\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2013.08.006.","journal-title":"J Control Release."},{"key":"3531_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/pharmaceutics17010136","volume":"17","author":"S Jacob","year":"2025","unstructured":"Jacob S, Kather FS, Boddu SHS, Attimarad M, Nair AB. Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques. Pharmaceutics. 2025;17:136. https:\/\/doi.org\/10.3390\/pharmaceutics17010136.","journal-title":"Pharmaceutics."},{"key":"3531_CR30","doi-asserted-by":"publisher","first-page":"17410","DOI":"10.1021\/acs.langmuir.4c01517","volume":"40","author":"VM Gowtham","year":"2024","unstructured":"Gowtham VM, Deodhar S, Thampi SP, Basavaraj MG. Association in Like-Charged Surfactant-Nanoparticle Systems: Interfacial and Bulk Effects. Langmuir. 2024;40:17410\u201322. https:\/\/doi.org\/10.1021\/acs.langmuir.4c01517.","journal-title":"Langmuir."},{"key":"3531_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.powtec.2014.01.095","volume":"257","author":"DR Ely","year":"2014","unstructured":"Ely DR, Edwin Garc\u00eda R, Thommes M. Ostwald\u2013Freundlich diffusion-limited dissolution kinetics of nanoparticles. Powder Technol. 2014;257:120\u20133. https:\/\/doi.org\/10.1016\/j.powtec.2014.01.095.","journal-title":"Powder Technol"},{"key":"3531_CR32","doi-asserted-by":"publisher","unstructured":"Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, et al. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels. Basel, Switzerland; 2022;8:82. https:\/\/doi.org\/10.3390\/gels8020082","DOI":"10.3390\/gels8020082"},{"key":"3531_CR33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/jop.2020.0022","volume":"36","author":"A Popov","year":"2020","unstructured":"Popov A. Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions. J Ocul Pharmacol Ther. 2020;36:366\u201375. https:\/\/doi.org\/10.1089\/jop.2020.0022.","journal-title":"J Ocul Pharmacol Ther."},{"key":"3531_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/1389201021999200820154918","volume":"22","author":"T Qin","year":"2021","unstructured":"Qin T, Dai Z, Xu X, Zhang Z, You X, Sun H, et al. Nanosuspension as an Efficient Carrier for Improved Ocular Permeation of Voriconazole. Curr Pharm Biotechnol. 2021;22:245\u201353. https:\/\/doi.org\/10.2174\/1389201021999200820154918.","journal-title":"Curr Pharm Biotechnol."},{"key":"3531_CR35","doi-asserted-by":"publisher","unstructured":"Ye T, Yuan K, Zhang W, Song S, Chen F, Yang X, et al. Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery. Asian Journal of Pharmaceutical Sciences [Internet]. 2013 [cited 2026 Mar 16];8:207\u201317. https:\/\/doi.org\/10.1016\/j.ajps.2013.09.002","DOI":"10.1016\/j.ajps.2013.09.002"},{"key":"3531_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2010.10.007","volume":"149","author":"HSM Ali","year":"2011","unstructured":"Ali HSM, York P, Ali AMA, Blagden N. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling. J Control Release. 2011;149:175\u201381. https:\/\/doi.org\/10.1016\/j.jconrel.2010.10.007.","journal-title":"J Control Release."},{"key":"3531_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijbiomac.2015.11.070","volume":"84","author":"SB da Silva","year":"2016","unstructured":"da Silva SB, Ferreira D, Pintado M, Sarmento B. Chitosan-based nanoparticles for rosmarinic acid ocular delivery\u2013In vitro tests. Int J Biol Macromol. 2016;84:112\u201320. https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.11.070.","journal-title":"Int J Biol Macromol."},{"key":"3531_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.nano.2010.07.003","volume":"7","author":"S Das","year":"2011","unstructured":"Das S, Suresh PK. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B Nanomedicine. 2011;7:242\u20137. https:\/\/doi.org\/10.1016\/j.nano.2010.07.003.","journal-title":"Application to amphotericin B. Nanomedicine."},{"key":"3531_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118808","volume":"572","author":"G Roy","year":"2019","unstructured":"Roy G, Galigama RD, Thorat VS, Mallela LS, Roy S, Garg P, et al. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis. Int J Pharm. 2019;572:118808. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118808.","journal-title":"Int J Pharm."},{"key":"3531_CR40","doi-asserted-by":"publisher","first-page":"15352","DOI":"10.3390\/ijms242015352","volume":"24","author":"L-C Liu","year":"2023","unstructured":"Liu L-C, Chen Y-H, Lu D-W. Overview of Recent Advances in Nano-Based Ocular Drug Delivery. Int J Mol Sci. 2023;24:15352. https:\/\/doi.org\/10.3390\/ijms242015352.","journal-title":"Int J Mol Sci."},{"key":"3531_CR41","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.2174\/138161209788923886","volume":"15","author":"S Wadhwa","year":"2009","unstructured":"Wadhwa S, Paliwal R, Paliwal SR, Vyas SP. Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des. 2009;15:2724\u201350. https:\/\/doi.org\/10.2174\/138161209788923886.","journal-title":"Curr Pharm Des."},{"key":"3531_CR42","doi-asserted-by":"publisher","unstructured":"Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, et al. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv [Internet]. The Royal Society of Chemistry; 2020 [cited 2026 June 24];10:27835\u201355. https:\/\/doi.org\/10.1039\/D0RA04971A","DOI":"10.1039\/D0RA04971A"},{"key":"3531_CR43","doi-asserted-by":"publisher","unstructured":"Qamar Z, Qizilbash FF, Iqubal MK, Ali A, Narang JK, Ali J, et al. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective. Recent patents on drug delivery & formulation [Internet]. Bentham Science Publishers; 2019 [cited 2026 June 24]; https:\/\/doi.org\/10.2174\/1872211314666191224115211","DOI":"10.2174\/1872211314666191224115211"},{"key":"3531_CR44","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.3390\/ijms24129824","volume":"24","author":"G Zuccari","year":"2023","unstructured":"Zuccari G, Alfei S. Development of Phytochemical Delivery Systems by Nano-Suspension and Nano-Emulsion Techniques. Int J Mol Sci. 2023;24:9824. https:\/\/doi.org\/10.3390\/ijms24129824.","journal-title":"Int J Mol Sci."},{"key":"3531_CR45","volume-title":"Processed excipients in advanced drug delivery","author":"T Pandya","year":"2025","unstructured":"Pandya T, Suthar D, Parikh K, Pathak R, Prajapati BG. Processed excipients in the formulation of nanocarriers. In: Processed excipients in advanced drug delivery. Apple Academic Press; 2025."},{"key":"3531_CR46","doi-asserted-by":"publisher","unstructured":"Gupta S, Samanta MK, Raichur AM. Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy. AAPS PharmSciTech [Internet]. 2010 [cited 2026 June 24];11:322\u201335. https:\/\/doi.org\/10.1208\/s12249-010-9388-x","DOI":"10.1208\/s12249-010-9388-x"},{"key":"3531_CR47","doi-asserted-by":"publisher","unstructured":"P\u0131nar SG, Oktay AN, Karak\u00fc\u00e7\u00fck AE, \u00c7elebi N. Formulation Strategies of Nanosuspensions for Various Administration Routes. Pharmaceutics [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 June 24];15:1520. https:\/\/doi.org\/10.3390\/pharmaceutics15051520","DOI":"10.3390\/pharmaceutics15051520"},{"key":"3531_CR48","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.2174\/1381612821666150901105026","volume":"21","author":"A Chen","year":"2015","unstructured":"Chen A, Shi Y, Yan Z, Hao H, Zhang Y, Zhong J, et al. Dosage form developments of nanosuspension drug delivery system for oral administration route. Curr Pharm Des. 2015;21:4355\u201365.","journal-title":"Curr Pharm Des"},{"key":"3531_CR49","doi-asserted-by":"publisher","unstructured":"Yadollahi R, Vasilev K, Simovic S. Nanosuspension Technologies for Delivery of Poorly Soluble Drugs. Journal of Nanomaterials [Internet]. 2015 [cited 2026 June 24];2015:216375. https:\/\/doi.org\/10.1155\/2015\/216375","DOI":"10.1155\/2015\/216375"},{"key":"3531_CR50","doi-asserted-by":"publisher","unstructured":"Rana P, Murthy RSR. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism. Drug Delivery [Internet]. Taylor & Francis; 2013 [cited 2026 June 24];20:224\u201335. https:\/\/doi.org\/10.3109\/10717544.2013.779331","DOI":"10.3109\/10717544.2013.779331"},{"key":"3531_CR51","doi-asserted-by":"publisher","unstructured":"Das S, Suresh PK. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomedicine: Nanotechnology, Biology and Medicine [Internet]. 2011 [cited 2026 June 24];7:242\u20137. https:\/\/doi.org\/10.1016\/j.nano.2010.07.003","DOI":"10.1016\/j.nano.2010.07.003"},{"key":"3531_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.03.038","volume":"430","author":"G Kaptay","year":"2012","unstructured":"Kaptay G. On the size and shape dependence of the solubility of nano-particles in solutions. Int J Pharm. 2012;430:253\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.03.038.","journal-title":"Int J Pharm."},{"key":"3531_CR53","doi-asserted-by":"publisher","first-page":"1561324","DOI":"10.3389\/fcell.2025.1561324","volume":"13","author":"R Mart\u00ednez-Carrasco","year":"2025","unstructured":"Mart\u00ednez-Carrasco R, Sharma A. Ocular surface glycocalyx in health and disease. Front Cell Dev Biol. 2025;13:1561324. https:\/\/doi.org\/10.3389\/fcell.2025.1561324.","journal-title":"Front Cell Dev Biol."},{"key":"3531_CR54","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbagen.2014.05.003","volume":"1850","author":"AP Corfield","year":"2015","unstructured":"Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal protection. Biochim Biophys Acta. 2015;1850:236\u201352. https:\/\/doi.org\/10.1016\/j.bbagen.2014.05.003.","journal-title":"Biochim Biophys Acta."},{"key":"3531_CR55","doi-asserted-by":"publisher","unstructured":"Zhang N, Zabotina OA. Critical Determinants in ER-Golgi Trafficking of Enzymes Involved in Glycosylation. Plants (Basel). Basel, Switzerland; 2022;11:428. https:\/\/doi.org\/10.3390\/plants11030428","DOI":"10.3390\/plants11030428"},{"key":"3531_CR56","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/glycob\/cwr182","volume":"22","author":"EP Bennett","year":"2012","unstructured":"Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2012;22:736\u201356. https:\/\/doi.org\/10.1093\/glycob\/cwr182.","journal-title":"Glycobiology"},{"issue":"Suppl 1","key":"3531_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12886-015-0137-5","volume":"15","author":"K Shirai","year":"2015","unstructured":"Shirai K, Saika S. Ocular surface mucins and local inflammation\u2013studies in genetically modified mouse lines. BMC Ophthalmol. 2015;15(Suppl 1):154. https:\/\/doi.org\/10.1186\/s12886-015-0137-5.","journal-title":"BMC Ophthalmol."},{"key":"3531_CR58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.preteyeres.2018.11.007","volume":"71","author":"C Baudouin","year":"2019","unstructured":"Baudouin C, Rolando M, Benitez Del Castillo JM, Messmer EM, Figueiredo FC, Irkec M, et al. Reconsidering the central role of mucins in dry eye and ocular surface diseases. Prog Retin Eye Res. 2019;71:68\u201387. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.11.007.","journal-title":"Prog Retin Eye Res."},{"key":"3531_CR59","doi-asserted-by":"publisher","first-page":"2499752","DOI":"10.1080\/21688370.2025.2499752","volume":"13","author":"F Fan","year":"2025","unstructured":"Fan F, Guo R, Pan K, Xu H, Chu X. Mucus and mucin: changes in the mucus barrier in disease states. Tissue Barriers. 2025;13:2499752. https:\/\/doi.org\/10.1080\/21688370.2025.2499752.","journal-title":"Tissue Barriers."},{"key":"3531_CR60","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1038\/s41598-018-24223-3","volume":"8","author":"OW Meldrum","year":"2018","unstructured":"Meldrum OW, Yakubov GE, Bonilla MR, Deshmukh O, McGuckin MA, Gidley MJ. Mucin gel assembly is controlled by a collective action of non-mucin proteins, disulfide bridges, Ca2+-mediated links, and hydrogen bonding. Sci Rep. 2018;8:5802. https:\/\/doi.org\/10.1038\/s41598-018-24223-3.","journal-title":"Sci Rep."},{"key":"3531_CR61","doi-asserted-by":"publisher","unstructured":"Plender EG, Prodanov T, Hsieh P, Nizamis E, Harvey WT, Sulovari A, et al. Structural and genetic diversity in the secreted mucins, MUC5AC and MUC5B. bioRxiv. 2024;2024.03.18.585560. https:\/\/doi.org\/10.1101\/2024.03.18.585560","DOI":"10.1101\/2024.03.18.585560"},{"key":"3531_CR62","doi-asserted-by":"publisher","first-page":"17503","DOI":"10.1038\/s41598-018-35499-w","volume":"8","author":"F Svensson","year":"2018","unstructured":"Svensson F, Lang T, Johansson MEV, Hansson GC. The central exons of the human MUC2 and MUC6 mucins are highly repetitive and variable in sequence between individuals. Sci Rep. 2018;8:17503. https:\/\/doi.org\/10.1038\/s41598-018-35499-w.","journal-title":"Sci Rep."},{"key":"3531_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.856962","volume":"12","author":"YH Sheng","year":"2022","unstructured":"Sheng YH, Hasnain SZ. Mucus and Mucins: The Underappreciated Host Defence System. Front Cell Infect Microbiol. 2022;12:856962. https:\/\/doi.org\/10.3389\/fcimb.2022.856962.","journal-title":"Front Cell Infect Microbiol."},{"key":"3531_CR64","doi-asserted-by":"publisher","unstructured":"Ik G. Distribution of mucins at the ocular surface. Experimental eye research [Internet]. Exp Eye Res; 2004 [cited 2026 Mar 17];78. https:\/\/doi.org\/10.1016\/s0014-4835(03)00204-5","DOI":"10.1016\/s0014-4835(03)00204-5"},{"key":"3531_CR65","doi-asserted-by":"publisher","unstructured":"Guzman-Aranguez A, Arg\u00fceso P. Structure and Biological Roles of Mucin-type O-glycans at the Ocular Surface. Ocul Surf [Internet]. 2010 [cited 2026 Mar 17];8:8\u201317. https:\/\/doi.org\/10.1016\/s1542-0124(12)70213-6","DOI":"10.1016\/s1542-0124(12)70213-6"},{"key":"3531_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0074-7696(03)31001-0","volume":"231","author":"IK Gipson","year":"2003","unstructured":"Gipson IK, Arg\u00fceso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol. 2003;231:1\u201349. https:\/\/doi.org\/10.1016\/s0074-7696(03)31001-0.","journal-title":"Int Rev Cytol."},{"key":"3531_CR67","doi-asserted-by":"publisher","first-page":"13558","DOI":"10.1038\/s41598-023-40491-0","volume":"13","author":"R Martinez-Carrasco","year":"2023","unstructured":"Martinez-Carrasco R, Rachagani S, Batra SK, Arg\u00fceso P, Fini ME. Roles unveiled for membrane-associated mucins at the ocular surface using a Muc4 knockout mouse model. Sci Rep. 2023;13:13558. https:\/\/doi.org\/10.1038\/s41598-023-40491-0.","journal-title":"Sci Rep."},{"key":"3531_CR68","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/mi.2014.127","volume":"8","author":"BB Menon","year":"2015","unstructured":"Menon BB, Kaiser-Marko C, Spurr-Michaud S, Tisdale AS, Gipson IK. Suppression of Toll-like receptor-mediated innate immune responses at the ocular surface by the membrane-associated mucins MUC1 and MUC16. Mucosal Immunol. 2015;8:1000\u20138. https:\/\/doi.org\/10.1038\/mi.2014.127.","journal-title":"Mucosal Immunol."},{"key":"3531_CR69","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1038\/srep10248","volume":"5","author":"T Nakamura","year":"2015","unstructured":"Nakamura T, Hata Y, Nagata M, Yokoi N, Yamaguchi S, Kaku T, et al. JBP485 promotes tear and mucin secretion in ocular surface epithelia. Sci Rep. 2015;5:10248. https:\/\/doi.org\/10.1038\/srep10248.","journal-title":"Sci Rep."},{"key":"3531_CR70","doi-asserted-by":"publisher","unstructured":"Dhar P, McAuley J. The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation. Front Cell Infect Microbiol [Internet]. Frontiers; 2019 [cited 2026 Mar 21];9. https:\/\/doi.org\/10.3389\/fcimb.2019.00117","DOI":"10.3389\/fcimb.2019.00117"},{"key":"3531_CR71","unstructured":"Blalock TD, Spurr\u2013Michaud SJ, Tisdale A, Arg\u00fceso P, Gipson IK. Shedding of Membrane\u2013Associated Mucins on the Ocular Surface. Invest Ophthalmol Vis Sci [Internet]. The Association for Research in Vision and Ophthalmology; 2006 [cited 2026 Mar 21];47:5432\u20135432. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2395217. Accessed 21 Mar 2026"},{"key":"3531_CR72","doi-asserted-by":"publisher","unstructured":"J S, S Y. Assessment of Mucin-Associated Gene Expression Levels on the Ocular Surface. Methods in molecular biology (Clifton, NJ) [Internet]. Methods Mol Biol; 2024 [cited 2026 Mar 21];2763. https:\/\/doi.org\/10.1007\/978-1-0716-3670-1_21","DOI":"10.1007\/978-1-0716-3670-1_21"},{"key":"3531_CR73","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/1541-7786.MCR-06-0038","volume":"4","author":"EJ Thompson","year":"2006","unstructured":"Thompson EJ, Shanmugam K, Hattrup CL, Kotlarczyk KL, Gutierrez A, Bradley JM, et al. Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1\/2 and nuclear factor-kappaB pathways. Mol Cancer Res. 2006;4:489\u201397. https:\/\/doi.org\/10.1158\/1541-7786.MCR-06-0038.","journal-title":"Mol Cancer Res."},{"key":"3531_CR74","doi-asserted-by":"publisher","unstructured":"Blalock TD, Spurr-Michaud SJ, Tisdale AS, Heimer SR, Gilmore MS, Ramesh V, et al. Functions of MUC16 in Corneal Epithelial Cells. Invest Ophthalmol Vis Sci [Internet]. 2007 [cited 2026 Mar 21];48:4509\u201318. https:\/\/doi.org\/10.1167\/iovs.07-0430","DOI":"10.1167\/iovs.07-0430"},{"key":"3531_CR75","unstructured":"Mart\u00ednez-Carrasco R, Rachagani S, Batra S, Argueso P, Fini ME. Muc4 Knockout Disrupts the Ocular Surface Mucosal Barrier in Mice. Invest Ophthalmol Vis Sci [Internet]. The Association for Research in Vision and Ophthalmology; 2022 [cited 2026 Mar 21];63:3257-A0292. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2781079. Accessed 21 Mar 2026"},{"key":"3531_CR76","doi-asserted-by":"publisher","unstructured":"Arg\u00fceso P, Woodward AM, AbuSamra DB. The Epithelial Cell Glycocalyx in Ocular Surface Infection. Front Immunol [Internet]. Frontiers; 2021 [cited 2026 Mar 21];12. https:\/\/doi.org\/10.3389\/fimmu.2021.729260","DOI":"10.3389\/fimmu.2021.729260"},{"key":"3531_CR77","doi-asserted-by":"publisher","unstructured":"Hori Y. Secreted Mucins on the Ocular Surface. Invest Ophthalmol Vis Sci. 2018;59:DES151\u20136. https:\/\/doi.org\/10.1167\/iovs.17-23623","DOI":"10.1167\/iovs.17-23623"},{"key":"3531_CR78","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1165\/rcmb.2007-0336RC","volume":"38","author":"K Ueno","year":"2008","unstructured":"Ueno K, Koga T, Kato K, Golenbock DT, Gendler SJ, Kai H, et al. MUC1 mucin is a negative regulator of Toll-like receptor signaling. Am J Respir Cell Mol Biol. 2008;38:263\u20138. https:\/\/doi.org\/10.1165\/rcmb.2007-0336RC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3531_CR79","doi-asserted-by":"publisher","unstructured":"Kato K, Lillehoj EP, Park YS, Umehara T, Hoffman NE, Madesh M, et al. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88. J Immunol. Baltimore, Md.\u202f: 1950; 2012;188:2014\u201322. https:\/\/doi.org\/10.4049\/jimmunol.1102405","DOI":"10.4049\/jimmunol.1102405"},{"key":"3531_CR80","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4:45\u201360. https:\/\/doi.org\/10.1038\/nrc1251.","journal-title":"Nat Rev Cancer."},{"key":"3531_CR81","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev.physiol.70.113006.100702","volume":"70","author":"DJ Thornton","year":"2008","unstructured":"Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70:459\u201386. https:\/\/doi.org\/10.1146\/annurev.physiol.70.113006.100702.","journal-title":"Annu Rev Physiol."},{"key":"3531_CR82","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/mi.2008.5","volume":"1","author":"SK Linden","year":"2008","unstructured":"Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal Immunol. 2008;1:183\u201397. https:\/\/doi.org\/10.1038\/mi.2008.5.","journal-title":"Mucosal Immunol."},{"key":"3531_CR83","doi-asserted-by":"publisher","unstructured":"Gipson IK, Inatomi T. Mucin genes expressed by the ocular surface Epithelium. Progress in Retinal and Eye Research [Internet]. 1997 [cited 2026 Mar 21];16:81\u201398. https:\/\/doi.org\/10.1016\/S1350-9462(96)00022-5","DOI":"10.1016\/S1350-9462(96)00022-5"},{"key":"3531_CR84","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1167\/iovs.11-7655","volume":"52","author":"RM Corrales","year":"2011","unstructured":"Corrales RM, Narayanan S, Fern\u00e1ndez I, Mayo A, Galarreta DJ, Fuentes-P\u00e1ez G, et al. Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Invest Ophthalmol Vis Sci. 2011;52:8363\u20139. https:\/\/doi.org\/10.1167\/iovs.11-7655.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"3531_CR85","first-page":"1004","volume":"43","author":"P Arg\u00fceso","year":"2002","unstructured":"Arg\u00fceso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sj\u00f6gren syndrome. Invest Ophthalmol Vis Sci. 2002;43:1004\u201311.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"3531_CR86","doi-asserted-by":"publisher","unstructured":"van Setten G-B. Cellular Stress in Dry Eye Disease\u2014Key Hub of the Vicious Circle. Biology (Basel) [Internet]. 2024 [cited 2026 Mar 21];13:669. https:\/\/doi.org\/10.3390\/biology13090669","DOI":"10.3390\/biology13090669"},{"key":"3531_CR87","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/pharmaceutics16081074","volume":"16","author":"L Badger-Emeka","year":"2024","unstructured":"Badger-Emeka L, Emeka P, Thirugnanasambantham K, Alatawi AS. The Role of Pseudomonas aeruginosa in the Pathogenesis of Corneal Ulcer, Its Associated Virulence Factors, and Suggested Novel Treatment Approaches. Pharmaceutics. 2024;16:1074. https:\/\/doi.org\/10.3390\/pharmaceutics16081074.","journal-title":"Pharmaceutics."},{"key":"3531_CR88","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1042\/BST20170408","volume":"46","author":"MC Rodriguez Benavente","year":"2018","unstructured":"Rodriguez Benavente MC, Arg\u00fceso P. Glycosylation pathways at the ocular surface. Biochem Soc Trans. 2018;46:343\u201350. https:\/\/doi.org\/10.1042\/BST20170408.","journal-title":"Biochem Soc Trans."},{"key":"3531_CR89","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajpath.2018.10.012","volume":"189","author":"AM Woodward","year":"2019","unstructured":"Woodward AM, Lehoux S, Mantelli F, Di Zazzo A, Brockhausen I, Bonini S, et al. Inflammatory Stress Causes N-Glycan Processing Deficiency in Ocular Autoimmune Disease. Am J Pathol. 2019;189:283\u201394. https:\/\/doi.org\/10.1016\/j.ajpath.2018.10.012.","journal-title":"Am J Pathol."},{"key":"3531_CR90","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bpg.2013.03.001","volume":"27","author":"JP Ouwerkerk","year":"2013","unstructured":"Ouwerkerk JP, de Vos WM, Belzer C. Glycobiome: bacteria and mucus at the epithelial interface. Best Pract Res Clin Gastroenterol. 2013;27:25\u201338. https:\/\/doi.org\/10.1016\/j.bpg.2013.03.001.","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"3531_CR91","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1167\/iovs.06-0656","volume":"48","author":"AJ Zandy","year":"2007","unstructured":"Zandy AJ, Bassnett S. Proteolytic mechanisms underlying mitochondrial degradation in the ocular lens. Invest Ophthalmol Vis Sci. 2007;48:293\u2013302. https:\/\/doi.org\/10.1167\/iovs.06-0656.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"3531_CR92","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1146\/annurev-biochem-011520-105053","volume":"89","author":"GC Hansson","year":"2020","unstructured":"Hansson GC. Mucins and the Microbiome. Annu Rev Biochem. 2020;89:769\u201393. https:\/\/doi.org\/10.1146\/annurev-biochem-011520-105053.","journal-title":"Annu Rev Biochem."},{"key":"3531_CR93","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11274-021-03145-9","volume":"37","author":"KK Selwal","year":"2021","unstructured":"Selwal KK, Selwal MK, Yu Z. Mucolytic bacteria: prevalence in various pathological diseases. World J Microbiol Biotechnol. 2021;37:176. https:\/\/doi.org\/10.1007\/s11274-021-03145-9.","journal-title":"World J Microbiol Biotechnol."},{"key":"3531_CR94","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/07853890510007340","volume":"37","author":"S Olofsson","year":"2005","unstructured":"Olofsson S, Bergstr\u00f6m T. Glycoconjugate glycans as viral receptors. Ann Med. 2005;37:154\u201372. https:\/\/doi.org\/10.1080\/07853890510007340.","journal-title":"Ann Med."},{"key":"3531_CR95","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.freeradbiomed.2008.04.026","volume":"45","author":"M Aslan","year":"2008","unstructured":"Aslan M, Cort A, Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic Biol Med. 2008;45:367\u201376. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.04.026.","journal-title":"Free Radic Biol Med."},{"key":"3531_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8110543","volume":"8","author":"A Cant\u00f3","year":"2019","unstructured":"Cant\u00f3 A, Olivar T, Romero FJ, Miranda M. Nitrosative stress in retinal pathologies: review. Antioxidants (Basel). 2019;8:543. https:\/\/doi.org\/10.3390\/antiox8110543.","journal-title":"Antioxidants (Basel)"},{"key":"3531_CR97","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/002215540205000306","volume":"50","author":"R Buddi","year":"2002","unstructured":"Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002;50:341\u201351. https:\/\/doi.org\/10.1177\/002215540205000306.","journal-title":"J Histochem Cytochem"},{"key":"3531_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cells5040043","volume":"5","author":"JH Dewald","year":"2016","unstructured":"Dewald JH, Colomb F, Bobowski-Gerard M, Groux-Degroote S, Delannoy P. Role of cytokine-induced glycosylation changes in regulating cell interactions and cell signaling in inflammatory diseases and cancer. Cells. 2016;5:43. https:\/\/doi.org\/10.3390\/cells5040043.","journal-title":"Cells"},{"key":"3531_CR99","doi-asserted-by":"publisher","unstructured":"Pai RV, Monpara JD, Vavia PR. Exploring molecular dynamics simulation to predict binding with ocular mucin: An in silico approach for screening mucoadhesive materials for ocular retentive delivery systems. Journal of Controlled Release [Internet]. 2019 [cited 2026 June 24];309:190\u2013202. https:\/\/doi.org\/10.1016\/j.jconrel.2019.07.037","DOI":"10.1016\/j.jconrel.2019.07.037"},{"key":"3531_CR100","doi-asserted-by":"publisher","unstructured":"Chang V, Chen RJ, Lian I, Mahoney KE, Romano J, Laurie G, et al. Site-specific O-glycans influence lacritin structure and multimerization in tears. bioRxiv [Internet]. 2026 [cited 2026 June 24];2026.03.30.715376. https:\/\/doi.org\/10.64898\/2026.03.30.715376","DOI":"10.64898\/2026.03.30.715376"},{"key":"3531_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72645-9","volume":"10","author":"MC Miller","year":"2020","unstructured":"Miller MC, Cai C, Wichapong K, Bhaduri S, Pohl NLB, Linhardt RJ, et al. Structural insight into the binding of human galectins to corneal keratan sulfate, its desulfated form and related saccharides. Sci Rep. 2020;10:15708. https:\/\/doi.org\/10.1038\/s41598-020-72645-9.","journal-title":"Sci Rep"},{"key":"3531_CR102","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s13346-025-02011-7","volume":"16","author":"A Sharma","year":"2026","unstructured":"Sharma A, Behera SK, Singh J, Beladiya J, Sheth D, Rana D, et al. Development, in silico, in vitro, and in vivo evaluation of gatiserts: HME-based ophthalmic inserts for prolonged ocular delivery of gatifloxacin. Drug Deliv Transl Res. 2026;16:1136\u201363. https:\/\/doi.org\/10.1007\/s13346-025-02011-7.","journal-title":"Drug Deliv Transl Res"},{"key":"3531_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00070-19","volume":"34","author":"SM Leal","year":"2021","unstructured":"Leal SM, Rodino KG, Fowler WC, Gilligan PH. Practical guidance for clinical microbiology laboratories: diagnosis of ocular infections. Clin Microbiol Rev. 2021;34:e00070-19. https:\/\/doi.org\/10.1128\/cmr.00070-19.","journal-title":"Clin Microbiol Rev"},{"key":"3531_CR104","doi-asserted-by":"publisher","unstructured":"Adigal SS, Rizvi A, Rayaroth NV, John RV, Barik A, Bhandari S, et al. Human tear fluid analysis for clinical applications: progress and prospects. Expert Review of Molecular Diagnostics. Taylor & Francis; 2021;21:767\u201387. https:\/\/doi.org\/10.1080\/14737159.2021.1941879","DOI":"10.1080\/14737159.2021.1941879"},{"key":"3531_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13167-016-0065-3","volume":"7","author":"S Hagan","year":"2016","unstructured":"Hagan S, Martin E, Enr\u00edquez-de-Salamanca A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. EPMA J. 2016;7:15. https:\/\/doi.org\/10.1186\/s13167-016-0065-3.","journal-title":"EPMA J."},{"key":"3531_CR106","doi-asserted-by":"publisher","first-page":"31168","DOI":"10.1021\/acsomega.3c03186","volume":"8","author":"M L\u00e9pine","year":"2023","unstructured":"L\u00e9pine M, Zambito O, Sleno L. Targeted Workflow Investigating Variations in the Tear Proteome by Liquid Chromatography Tandem Mass Spectrometry. ACS Omega American Chemical Society. 2023;8:31168\u201377. https:\/\/doi.org\/10.1021\/acsomega.3c03186.","journal-title":"ACS Omega. American Chemical Society"},{"key":"3531_CR107","doi-asserted-by":"publisher","unstructured":"Alenezi H, Parnell G, Schibeci S, Ozkan J, Willcox M, White AJR, et al. Ocular surface immune transcriptome and tear cytokines in corneal infection patients. Front Cell Infect Microbiol [Internet]. Frontiers; 2024 [cited 2026 Jan 7];14. https:\/\/doi.org\/10.3389\/fcimb.2024.1346821","DOI":"10.3389\/fcimb.2024.1346821"},{"key":"3531_CR108","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/biomedicines13020386","volume":"13","author":"K Frenia","year":"2025","unstructured":"Frenia K, Fu Y, Beatty MA, Garwood KC, Kimmel J, Raiji V, et al. Precision in Tear Fluid Biomarker Discovery: Quantitative Proteomic Profiling of Small-Volume, Individual Samples Using Capillary Tube Collection. Biomedicines. 2025;13:386. https:\/\/doi.org\/10.3390\/biomedicines13020386.","journal-title":"Biomedicines."},{"key":"3531_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101338","volume":"106","author":"M Gijs","year":"2025","unstructured":"Gijs M, van de Sande N, Bonnet C, Schmeetz J, Fernandes R, Trav\u00e9-Huarte S, et al. A comprehensive scoping review of methodological approaches and clinical applications of tear fluid biomarkers. Progress in Retinal and Eye Research. 2025;106:101338. https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101338.","journal-title":"Progress in Retinal and Eye Research."},{"key":"3531_CR110","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","volume":"17","author":"ME Stern","year":"1998","unstructured":"Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584\u20139. https:\/\/doi.org\/10.1097\/00003226-199811000-00002.","journal-title":"Cornea."},{"key":"3531_CR111","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2415-13-40","volume":"13","author":"Z Torok","year":"2013","unstructured":"Torok Z, Peto T, Csosz E, Tukacs E, Molnar A, Maros-Szabo Z, et al. Tear fluid proteomics multimarkers for diabetic retinopathy screening. BMC Ophthalmol. 2013;13:40. https:\/\/doi.org\/10.1186\/1471-2415-13-40.","journal-title":"BMC Ophthalmol."},{"key":"3531_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2015.04.002","volume":"480","author":"C Aass","year":"2015","unstructured":"Aass C, Norheim I, Eriksen EF, Thorsby PM, Pepaj M. Single unit filter-aided method for fast proteomic analysis of tear fluid. Anal Biochem. 2015;480:1\u20135. https:\/\/doi.org\/10.1016\/j.ab.2015.04.002.","journal-title":"Anal Biochem."},{"key":"3531_CR113","doi-asserted-by":"publisher","unstructured":"Smith J. The epidemiology of dry eye disease. Acta Ophthalmologica Scandinavica. 2007;85:0\u20130. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.01063_2858.x","DOI":"10.1111\/j.1600-0420.2007.01063_2858.x"},{"key":"3531_CR114","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","volume":"21","author":"NJ Friedman","year":"2010","unstructured":"Friedman NJ. Impact of dry eye disease and treatment on quality of life. Current Opinion in Ophthalmology. 2010;21:310. https:\/\/doi.org\/10.1097\/ICU.0b013e32833a8c15.","journal-title":"Current Opinion in Ophthalmology."},{"key":"3531_CR115","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","volume":"14","author":"NL Lanza","year":"2016","unstructured":"Lanza NL, Valenzuela F, Perez VL, Galor A. The matrix metalloproteinase 9 point-of-care test in dry eye. Ocul Surf. 2016;14:189\u201395. https:\/\/doi.org\/10.1016\/j.jtos.2015.10.004.","journal-title":"Ocul Surf"},{"key":"3531_CR116","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/aos.15059","volume":"100","author":"J N\u00e4ttinen","year":"2022","unstructured":"N\u00e4ttinen J, Aapola U, Nukareddy P, Uusitalo H. Looking deeper into ocular surface health: an introduction to clinical tear proteomics analysis. Acta Ophthalmologica. 2022;100:486\u201398. https:\/\/doi.org\/10.1111\/aos.15059.","journal-title":"Acta Ophthalmologica."},{"key":"3531_CR117","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/iovs.66.14.11","volume":"66","author":"R Li","year":"2025","unstructured":"Li R, Zhang H, Yang L, Pan Y, Wei Y, Sun J, et al. High-Throughput Tear Proteomics Reveals Multi-Faceted Signatures of Thyroid Eye Disease. Invest Ophthalmol Vis Sci. 2025;66:11. https:\/\/doi.org\/10.1167\/iovs.66.14.11.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"3531_CR118","doi-asserted-by":"publisher","unstructured":"Gagan S, Joseph J. Biomarkers and Emerging Therapeutic Strategies in HSK: Bridging Diagnostics and Treatment. Current Eye Research. Taylor & Francis; 2025;0:1\u201315. https:\/\/doi.org\/10.1080\/02713683.2025.2589345","DOI":"10.1080\/02713683.2025.2589345"},{"key":"3531_CR119","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12886-025-03875-6","volume":"25","author":"J Zhang","year":"2025","unstructured":"Zhang J, Wu Z, Zhang Y, Wu K, Li X, Zhou S. Tear metabolomics reveals novel potential biomarkers in epithelial herpes simplex keratitis. BMC Ophthalmol. 2025;25:43. https:\/\/doi.org\/10.1186\/s12886-025-03875-6.","journal-title":"BMC Ophthalmol."},{"key":"3531_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109121","volume":"221","author":"T Su\u00e1rez-Cort\u00e9s","year":"2022","unstructured":"Su\u00e1rez-Cort\u00e9s T, Merino-Inda N, Benitez-del-Castillo JM. Tear and ocular surface disease biomarkers: A diagnostic and clinical perspective for ocular allergies and dry eye disease. Experimental Eye Research. 2022;221:109121. https:\/\/doi.org\/10.1016\/j.exer.2022.109121.","journal-title":"Experimental Eye Research."},{"key":"3531_CR121","doi-asserted-by":"publisher","first-page":"1577656","DOI":"10.3389\/fmed.2025.1577656","volume":"12","author":"X Shang","year":"2025","unstructured":"Shang X, Zhang Y, Luo S, Liu M, Li H, Fang X, et al. Tear IgE point-of-care testing for differentiating type I and type IV allergic conjunctivitis. Front Med (Lausanne). 2025;12:1577656. https:\/\/doi.org\/10.3389\/fmed.2025.1577656.","journal-title":"Front Med (Lausanne)."},{"key":"3531_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052041","author":"R Comito","year":"2025","unstructured":"Comito R, Ciavarella C, Astolfi G, Conti M, Porru E, Violante FS, et al. Tear sampling and biomarker discovery: a robust workflow for routine clinical applications using UHPLC-MS\/MS and Schirmer strips. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26052041.","journal-title":"Int J Mol Sci"},{"key":"3531_CR123","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","volume":"57","author":"AV Farooq","year":"2012","unstructured":"Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57:448\u201362. https:\/\/doi.org\/10.1016\/j.survophthal.2012.01.005.","journal-title":"Surv Ophthalmol."},{"key":"3531_CR124","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s1542-0124(12)70081-2","volume":"5","author":"The definition and classification of dry eye disease","year":"2007","unstructured":"The definition and classification of dry eye disease. report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75\u201392. https:\/\/doi.org\/10.1016\/s1542-0124(12)70081-2.","journal-title":"Ocul Surf."},{"key":"3531_CR125","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1177\/0004563217695843","volume":"54","author":"A Rentka","year":"2017","unstructured":"Rentka A, Koroskenyi K, Harsfalvi J, Szekanecz Z, Szucs G, Szodoray P, et al. Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis. Ann Clin Biochem. 2017;54:521\u20139. https:\/\/doi.org\/10.1177\/0004563217695843.","journal-title":"Ann Clin Biochem."},{"key":"3531_CR126","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15:539\u201374. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001.","journal-title":"Ocul Surf."},{"key":"3531_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.03.001","volume":"63","author":"M Boerger","year":"2019","unstructured":"Boerger M, Funke S, Leha A, Roser A-E, Wuestemann A-K, Maass F, et al. Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson\u2019s disease - A pilot study. Parkinsonism Relat Disord. 2019;63:3\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.03.001.","journal-title":"Parkinsonism Relat Disord."},{"key":"3531_CR128","doi-asserted-by":"publisher","unstructured":"Arslan MA, Kolman I, Pionneau C, Chardonnet S, Magny R, Baudouin C, et al. Proteomic Analysis of Tears and Conjunctival Cells Collected with Schirmer Strips Using timsTOF Pro: Preanalytical Considerations. Metabolites [Internet]. 2021 [cited 2026 Jan 7];12. https:\/\/doi.org\/10.3390\/metabo12010002","DOI":"10.3390\/metabo12010002"},{"key":"3531_CR129","doi-asserted-by":"publisher","unstructured":"Menchicchi B, Fuenzalida JP, Bobbili KB, Hensel A, Swamy MJ, Goycoolea FM. Structure of Chitosan Determines Its Interactions with Mucin. Biomacromolecules [Internet]. American Chemical Society; 2014 [cited 2026 June 25];15:3550\u20138. https:\/\/doi.org\/10.1021\/bm5007954","DOI":"10.1021\/bm5007954"},{"key":"3531_CR130","doi-asserted-by":"publisher","unstructured":"Goostrey T, Ross M, Soliman K, Sheardown L, Sheardown H. Mucoadhesive micelles for ophthalmic drug delivery. J Biomater Appl [Internet]. SAGE Publications Ltd STM; 2026 [cited 2026 June 25];40:972\u201386. https:\/\/doi.org\/10.1177\/08853282251386004","DOI":"10.1177\/08853282251386004"},{"key":"3531_CR131","doi-asserted-by":"publisher","unstructured":"Gra\u00e7a A, Gon\u00e7alves LM, Raposo S, Ribeiro HM, Marto J. Useful In Vitro Techniques to Evaluate the Mucoadhesive Properties of Hyaluronic Acid-Based Ocular Delivery Systems. Pharmaceutics [Internet]. Multidisciplinary Digital Publishing Institute; 2018 [cited 2026 June 25];10:110. https:\/\/doi.org\/10.3390\/pharmaceutics10030110","DOI":"10.3390\/pharmaceutics10030110"},{"key":"3531_CR132","doi-asserted-by":"publisher","unstructured":"Ra\u010di\u0107 A, Kraji\u0161nik D. Biopolymers in Mucoadhesive Eye Drops for Treatment of Dry Eye and Allergic Conditions: Application and Perspectives. Pharmaceutics [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 June 25];15:470. https:\/\/doi.org\/10.3390\/pharmaceutics15020470","DOI":"10.3390\/pharmaceutics15020470"},{"key":"3531_CR133","doi-asserted-by":"publisher","unstructured":"Alkholief M, Kalam MA, Alshememry AK, Ali R, Alhudaithi SS, Alsaleh NB, et al. Topical Application of Linezolid\u2013Loaded Chitosan Nanoparticles for the Treatment of Eye Infections. Nanomaterials [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 Mar 22];13:681. https:\/\/doi.org\/10.3390\/nano13040681","DOI":"10.3390\/nano13040681"},{"key":"3531_CR134","doi-asserted-by":"publisher","unstructured":"Lai SK, Wang Y-Y, Wirtz D, Hanes J. Micro- and macrorheology of mucus. Advanced Drug Delivery Reviews [Internet]. 2009 [cited 2026 June 25];61:86\u2013100. https:\/\/doi.org\/10.1016\/j.addr.2008.09.012","DOI":"10.1016\/j.addr.2008.09.012"},{"key":"3531_CR135","doi-asserted-by":"publisher","unstructured":"Desai N, Colley HE, Krishna Y, Bosworth LA, Kearns VR. Mucoadhesive nanofibers for ocular drug delivery: mechanisms, design strategies, and applications. Drug Deliv and Transl Res [Internet]. 2026 [cited 2026 May 31];16:1096\u2013135. https:\/\/doi.org\/10.1007\/s13346-025-01894-w","DOI":"10.1007\/s13346-025-01894-w"},{"key":"3531_CR136","doi-asserted-by":"publisher","unstructured":"Ensign LM, Henning A, Schneider CS, Maisel K, Wang Y-Y, Porosoff MD, et al. Ex Vivo Characterization of Particle Transport in Mucus Secretions Coating Freshly Excised Mucosal Tissues. Mol Pharmaceutics [Internet]. American Chemical Society; 2013 [cited 2026 June 25];10:2176\u201382. https:\/\/doi.org\/10.1021\/mp400087y","DOI":"10.1021\/mp400087y"},{"key":"3531_CR137","doi-asserted-by":"publisher","unstructured":"Boegh M, Nielsen HM. Mucus as a Barrier to Drug Delivery \u2013 Understanding and Mimicking the Barrier Properties. Basic & Clinical Pharmacology & Toxicology [Internet]. 2015 [cited 2026 June 25];116:179\u201386. https:\/\/doi.org\/10.1111\/bcpt.12342","DOI":"10.1111\/bcpt.12342"},{"key":"3531_CR138","doi-asserted-by":"publisher","unstructured":"Josyula A, Omiadze R, Parikh K, Kanvinde P, Appell MB, Patel P, et al. An ion-paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection. Bioengineering & Translational Medicine [Internet]. 2021 [cited 2026 June 25];6:e10238. https:\/\/doi.org\/10.1002\/btm2.10238","DOI":"10.1002\/btm2.10238"},{"key":"3531_CR139","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","volume":"57","author":"A Ludwig","year":"2005","unstructured":"Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57:1595\u2013639. https:\/\/doi.org\/10.1016\/j.addr.2005.07.005.","journal-title":"Adv Drug Deliv Rev."},{"key":"3531_CR140","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12:348\u201360. https:\/\/doi.org\/10.1208\/s12248-010-9183-3.","journal-title":"AAPS J."},{"key":"3531_CR141","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ACI.0b013e32830e6b04","volume":"8","author":"F Mantelli","year":"2008","unstructured":"Mantelli F, Arg\u00fceso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol. 2008;8:477\u201383. https:\/\/doi.org\/10.1097\/ACI.0b013e32830e6b04.","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"3531_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015352","volume":"24","author":"L-C Liu","year":"2023","unstructured":"Liu L-C, Chen Y-H, Lu D-W. Overview of recent advances in nano-based ocular drug delivery. Int J Mol Sci. 2023;24:15352. https:\/\/doi.org\/10.3390\/ijms24201535.","journal-title":"Int J Mol Sci"},{"key":"3531_CR143","doi-asserted-by":"publisher","first-page":"31751","DOI":"10.1074\/jbc.274.45.31751","volume":"274","author":"J Perez-Vilar","year":"1999","unstructured":"Perez-Vilar J, Hill RL. The structure and assembly of secreted mucins. J Biol Chem. 1999;274:31751\u20134. https:\/\/doi.org\/10.1074\/jbc.274.45.31751.","journal-title":"J Biol Chem."},{"key":"3531_CR144","doi-asserted-by":"publisher","unstructured":"Bravo-Osuna I, Noiray M, Briand E, Woodward AM, Arg\u00fceso P, Mart\u00ednez ITM, et al. Interfacial Interaction between Transmembrane Ocular Mucins and Adhesive Polymers and Dendrimers Analyzed by Surface Plasmon Resonance. Pharm Res [Internet]. 2012 [cited 2026 June 25];29:2329\u201340. https:\/\/doi.org\/10.1007\/s11095-012-0761-1","DOI":"10.1007\/s11095-012-0761-1"},{"key":"3531_CR145","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.exer.2010.02.014","volume":"90","author":"B Govindarajan","year":"2010","unstructured":"Govindarajan B, Gipson IK. Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res. 2010;90:655\u201363. https:\/\/doi.org\/10.1016\/j.exer.2010.02.014.","journal-title":"Exp Eye Res."},{"key":"3531_CR146","doi-asserted-by":"publisher","first-page":"23037","DOI":"10.1074\/jbc.M109.033332","volume":"284","author":"P Arg\u00fceso","year":"2009","unstructured":"Arg\u00fceso P, Guzman-Aranguez A, Mantelli F, Cao Z, Ricciuto J, Panjwani N. Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier. J Biol Chem. 2009;284:23037\u201345. https:\/\/doi.org\/10.1074\/jbc.M109.033332.","journal-title":"J Biol Chem."},{"key":"3531_CR147","doi-asserted-by":"publisher","unstructured":"Arg\u00fceso P, Gipson IK. Assessing mucin expression and function in human ocular surface epithelia in vivo and in vitro. Methods Mol Biol. Clifton, N.J.; 2012;842:313\u201325. https:\/\/doi.org\/10.1007\/978-1-61779-513-8_19","DOI":"10.1007\/978-1-61779-513-8_19"},{"key":"3531_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108115","volume":"197","author":"SC Pflugfelder","year":"2020","unstructured":"Pflugfelder SC, Stern ME. Biological functions of tear film. Exp Eye Res. 2020;197:108115. https:\/\/doi.org\/10.1016\/j.exer.2020.108115.","journal-title":"Exp Eye Res."},{"key":"3531_CR149","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","volume":"28","author":"ML Massingale","year":"2009","unstructured":"Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28:1023\u20137. https:\/\/doi.org\/10.1097\/ICO.0b013e3181a16578.","journal-title":"Cornea."},{"key":"3531_CR150","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","volume":"61","author":"RA Cone","year":"2009","unstructured":"Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61:75\u201385. https:\/\/doi.org\/10.1016\/j.addr.2008.09.008.","journal-title":"Adv Drug Deliv Rev."},{"key":"3531_CR151","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/mas.21691","volume":"41","author":"E Ponzini","year":"2022","unstructured":"Ponzini E, Santambrogio C, De Palma A, Mauri P, Tavazzi S, Grandori R. Mass spectrometry-based tear proteomics for noninvasive biomarker discovery. Mass Spectrom Rev. 2022;41:842\u201360. https:\/\/doi.org\/10.1002\/mas.21691.","journal-title":"Mass Spectrom Rev."},{"key":"3531_CR152","doi-asserted-by":"publisher","unstructured":"Fan Z, Hu Y, Chen L, Lu X, Zheng L, Ma D, et al. Multiplatform tear proteomic profiling reveals novel non-invasive biomarkers for diabetic retinopathy. Eye (Lond). London, England; 2024;38:1509\u201317. https:\/\/doi.org\/10.1038\/s41433-024-02938-0","DOI":"10.1038\/s41433-024-02938-0"},{"key":"3531_CR153","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.colsurfb.2011.12.020","volume":"92","author":"D Ivarsson","year":"2012","unstructured":"Ivarsson D, Wahlgren M. Comparison of in vitro methods of measuring mucoadhesion: ellipsometry, tensile strength and rheological measurements. Colloids Surf B Biointerfaces. 2012;92:353\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2011.12.020.","journal-title":"Colloids Surf B Biointerfaces."},{"key":"3531_CR154","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpba.2018.04.041","volume":"156","author":"S Rossi","year":"2018","unstructured":"Rossi S, Vigani B, Bonferoni MC, Sandri G, Caramella C, Ferrari F. Rheological analysis and mucoadhesion: A 30 year-old and still active combination. J Pharm Biomed Anal. 2018;156:232\u20138. https:\/\/doi.org\/10.1016\/j.jpba.2018.04.041.","journal-title":"J Pharm Biomed Anal."},{"key":"3531_CR155","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.3390\/polym15132773","volume":"15","author":"Z Fathalla","year":"2023","unstructured":"Fathalla Z, Fatease AA, Abdelkader H. Formulation and In-Vitro\/Ex-Vivo Characterization of Pregelled Hybrid Alginate-Chitosan Microparticles for Ocular Delivery of Ketorolac Tromethamine. Polymers (Basel). 2023;15:2773. https:\/\/doi.org\/10.3390\/polym15132773.","journal-title":"Polymers (Basel)."},{"key":"3531_CR156","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.3390\/polym14245459","volume":"14","author":"Z Jawadi","year":"2022","unstructured":"Jawadi Z, Yang C, Haidar ZS, Santa Maria PL, Massa S. Bio-Inspired Muco-Adhesive Polymers for Drug Delivery Applications. Polymers (Basel). 2022;14:5459. https:\/\/doi.org\/10.3390\/polym14245459.","journal-title":"Polymers (Basel)."},{"key":"3531_CR157","doi-asserted-by":"publisher","DOI":"10.1002\/admi.202200211","volume":"9","author":"IS Bayer","year":"2022","unstructured":"Bayer IS. Recent advances in mucoadhesive interface materials, mucoadhesion characterization, and technologies. Adv Mater Interfaces. 2022;9:2200211. https:\/\/doi.org\/10.1002\/admi.202200211.","journal-title":"Adv Mater Interfaces"},{"key":"3531_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2023.105908","volume":"143","author":"C Guarise","year":"2023","unstructured":"Guarise C, Acquasaliente L, Pasut G, Pavan M, Soato M, Garofolin G, et al. The role of high molecular weight hyaluronic acid in mucoadhesion on an ocular surface model. J Mech Behav Biomed Mater. 2023;143:105908. https:\/\/doi.org\/10.1016\/j.jmbbm.2023.105908.","journal-title":"J Mech Behav Biomed Mater."},{"key":"3531_CR159","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1021\/acs.biomac.6b00054","volume":"17","author":"G Prosperi-Porta","year":"2016","unstructured":"Prosperi-Porta G, Kedzior S, Muirhead B, Sheardown H. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery. Biomacromolecules. 2016;17:1449\u201357. https:\/\/doi.org\/10.1021\/acs.biomac.6b00054.","journal-title":"Biomacromolecules."},{"key":"3531_CR160","unstructured":"Sheardown LD, Ross M, Sheardown H, Wylie R. Mucoadhesive Polymer-Drug Conjugate for Use in Ophthalmic Drug Delivery | IOVS | ARVO Journals. [cited 2026 June 26]; https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2799824. Accessed 26 June 2026"},{"key":"3531_CR161","doi-asserted-by":"publisher","unstructured":"Alcantara KP, Pajimna RMB, Aliga PJS, Malabanan JWT, Tangwongsiri C, Haworth IS, et al. Review of Chitosan-Coated Nanoscale Liposomes for Enhanced Drug Delivery. ACS Appl Nano Mater [Internet]. American Chemical Society; 2025 [cited 2026 June 26];8:21125\u201347. https:\/\/doi.org\/10.1021\/acsanm.5c03463","DOI":"10.1021\/acsanm.5c03463"},{"key":"3531_CR162","doi-asserted-by":"publisher","unstructured":"Plikusiene I, Maciulis V, Ramanavicius A, Ramanaviciene A. Spectroscopic Ellipsometry and Quartz Crystal Microbalance with Dissipation for the Assessment of Polymer Layers and for the Application in Biosensing. Polymers [Internet]. Multidisciplinary Digital Publishing Institute; 2022 [cited 2026 June 26];14:1056. https:\/\/doi.org\/10.3390\/polym14051056","DOI":"10.3390\/polym14051056"},{"key":"3531_CR163","doi-asserted-by":"publisher","unstructured":"Argudo PG, Maestro A, Guzm\u00e1n E. Fluid Interfaces as Models for the Study of Lipid-Based Films with Biophysical Relevance. Coatings [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 June 26];13:1560. https:\/\/doi.org\/10.3390\/coatings13091560","DOI":"10.3390\/coatings13091560"},{"key":"3531_CR164","doi-asserted-by":"publisher","unstructured":"McMaster TJ, Berry M, Corfield AP, Miles MJ. Atomic Force Microscopy of the Submolecular Architecture of Hydrated Ocular Mucins. Biophysical Journal [Internet]. Elsevier; 1999 [cited 2026 June 26];77:533\u201341. https:\/\/doi.org\/10.1016\/S0006-3495(99)76910-9","DOI":"10.1016\/S0006-3495(99)76910-9"},{"key":"3531_CR165","doi-asserted-by":"publisher","unstructured":"Baos SC, Phillips DB, Wildling L, McMaster TJ, Berry M. Distribution of Sialic Acids on Mucins and Gels: A Defense Mechanism. Biophysical Journal [Internet]. Elsevier; 2012 [cited 2026 June 26];102:176\u201384. https:\/\/doi.org\/10.1016\/j.bpj.2011.08.058","DOI":"10.1016\/j.bpj.2011.08.058"},{"key":"3531_CR166","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1021\/acsapm.5c04369","volume":"8","author":"RRM Madrid","year":"2026","unstructured":"Madrid RRM, Mathews PD, Mertins O. Thermodynamic and conformational study on the interaction between pH-responsive polymer-shell cubosome and mucin for drug delivery applications. ACS Appl Polym Mater. 2026;8:2846\u201355. https:\/\/doi.org\/10.1021\/acsapm.5c04369.","journal-title":"ACS Appl Polym Mater"},{"key":"3531_CR167","doi-asserted-by":"publisher","unstructured":"Das S, D\u2019Souza S, Gorimanipalli B, Shetty R, Ghosh A, Deshpande V. Ocular Surface Infection Mediated Molecular Stress Responses: A Review. International Journal of Molecular Sciences [Internet]. Multidisciplinary Digital Publishing Institute; 2022 [cited 2026 Mar 21];23:3111. https:\/\/doi.org\/10.3390\/ijms23063111","DOI":"10.3390\/ijms23063111"},{"key":"3531_CR168","doi-asserted-by":"publisher","unstructured":"Fu R, Klinngam W, Heur M, Edman MC, Hamm-Alvarez SF. Tear proteases and protease inhibitors: potential biomarkers and disease drivers in ocular surface disease. Eye Contact Lens [Internet]. 2020 [cited 2026 Mar 21];46:S70\u201383. https:\/\/doi.org\/10.1097\/ICL.0000000000000641","DOI":"10.1097\/ICL.0000000000000641"},{"key":"3531_CR169","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1080\/02713683.2017.1377261","volume":"42","author":"CW McMonnies","year":"2017","unstructured":"McMonnies CW. Conjunctival Tear Layer Temperature, Evaporation, Hyperosmolarity, Inflammation, Hyperemia, Tissue Damage, and Symptoms: A Review of an Amplifying Cascade. Curr Eye Res. 2017;42:1574\u201384. https:\/\/doi.org\/10.1080\/02713683.2017.1377261.","journal-title":"Curr Eye Res."},{"key":"3531_CR170","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874364101509010049","volume":"9","author":"R Bola\u00f1os-Jim\u00e9nez","year":"2015","unstructured":"Bola\u00f1os-Jim\u00e9nez R, Navas A, L\u00f3pez-Liz\u00e1rraga EP, de Ribot FM, Pe\u00f1a A, Graue-Hern\u00e1ndez EO, et al. Ocular Surface as Barrier of Innate Immunity. Open Ophthalmol J. 2015;9:49\u201355. https:\/\/doi.org\/10.2174\/1874364101509010049.","journal-title":"Open Ophthalmol J."},{"key":"3531_CR171","doi-asserted-by":"publisher","unstructured":"Lambiase A, Micera A, Sacchetti M, Mantelli F, Bonini S. Toll-like receptors in ocular surface diseases: overview and new findings. Clin Sci (Lond). London, England\u202f: 1979; 2011;120:441\u201350. https:\/\/doi.org\/10.1042\/CS20100425","DOI":"10.1042\/CS20100425"},{"key":"3531_CR172","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajo.2019.01.002","volume":"200","author":"Y-H Kim","year":"2019","unstructured":"Kim Y-H, Li Z, Cui L, Li Y, Yoon H-J, Choi W, et al. Expression of Nod-like Receptors and Clinical Correlations in Patients With Dry Eye Disease. Am J Ophthalmol. 2019;200:150\u201360. https:\/\/doi.org\/10.1016\/j.ajo.2019.01.002.","journal-title":"Am J Ophthalmol."},{"key":"3531_CR173","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1038\/s41598-023-35144-1","volume":"13","author":"S Komai","year":"2023","unstructured":"Komai S, Ueta M, Nishigaki H, Mizushima K, Naito Y, Kinoshita S, et al. Differences in gene regulation by TLR3 and IPS-1 signaling in murine corneal epithelial cells. Sci Rep. 2023;13:7925. https:\/\/doi.org\/10.1038\/s41598-023-35144-1.","journal-title":"Sci Rep."},{"key":"3531_CR174","unstructured":"Li H. Toll\u2013like Receptor 7 Up\u2013regulation and NF\u2013kB Activation in Response to HSV\u20131 Infection in Corneal Epithelial Cells. Invest Ophthalmol Vis Sci [Internet]. The Association for Research in Vision and Ophthalmology; 2004 [cited 2026 Mar 21];45:1659\u20131659. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2407225. Accessed 21 Mar 2026"},{"key":"3531_CR175","doi-asserted-by":"publisher","unstructured":"Hou A, Tin MQ, Tong L. Toll-like receptor 2-mediated NF-kappa B pathway activation in ocular surface epithelial cells. Eye Vis (Lond). London, England; 2017;4:17. https:\/\/doi.org\/10.1186\/s40662-017-0082-x","DOI":"10.1186\/s40662-017-0082-x"},{"key":"3531_CR176","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13:460\u20139. https:\/\/doi.org\/10.1016\/j.molmed.2007.09.002.","journal-title":"Trends Mol Med."},{"key":"3531_CR177","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cei.13021","volume":"190","author":"BR Brown","year":"2017","unstructured":"Brown BR, Lee EJ, Snow PE, Vance EE, Iwakura Y, Ohno N, et al. Fungal-derived cues promote ocular autoimmunity through a Dectin-2\/Card9-mediated mechanism. Clin Exp Immunol. 2017;190:293\u2013303. https:\/\/doi.org\/10.1111\/cei.13021.","journal-title":"Clin Exp Immunol."},{"key":"3531_CR178","doi-asserted-by":"publisher","unstructured":"Vautier S, Sousa M da G, Brown GD. C-type lectins, fungi and Th17 responses. Cytokine Growth Factor Rev. 2010;21:405\u201312. https:\/\/doi.org\/10.1016\/j.cytogfr.2010.10.001","DOI":"10.1016\/j.cytogfr.2010.10.001"},{"key":"3531_CR179","doi-asserted-by":"publisher","unstructured":"Pearlman E, Sun Y, Roy S, Karmakar M, Hise AG, Szczotka-Flynn L, et al. Host Defense at the Ocular Surface. International Reviews of Immunology [Internet]. Taylor & Francis; 2013 [cited 2026 June 25];32:4\u201318. https:\/\/doi.org\/10.3109\/08830185.2012.749400","DOI":"10.3109\/08830185.2012.749400"},{"key":"3531_CR180","doi-asserted-by":"publisher","unstructured":"Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. British Journal of Ophthalmology [Internet]. BMJ Publishing Group Ltd; 2006 [cited 2026 June 25];90:103\u20138. https:\/\/doi.org\/10.1136\/bjo.2005.072686","DOI":"10.1136\/bjo.2005.072686"},{"key":"3531_CR181","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.survophthal.2008.12.004","volume":"54","author":"JE Knickelbein","year":"2009","unstructured":"Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol. 2009;54:226\u201334. https:\/\/doi.org\/10.1016\/j.survophthal.2008.12.004.","journal-title":"Surv Ophthalmol"},{"key":"3531_CR182","doi-asserted-by":"publisher","unstructured":"Bisen AC, Sanap SN, Agrawal S, Biswas A, Mishra A, Verma SK, et al. Etiopathology, Epidemiology, Diagnosis, and Treatment of Fungal Keratitis. ACS Infect Dis [Internet]. American Chemical Society; 2024 [cited 2026 June 25];10:2356\u201380. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00203","DOI":"10.1021\/acsinfecdis.4c00203"},{"key":"3531_CR183","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7569\/RAA.2014.097310","volume":"2","author":"A Khare","year":"2014","unstructured":"Khare A, Grover K, Pawar P, Singh I. Mucoadhesive Polymers for Enhancing Retention in Ocular Drug Delivery: A Critical Review. Reviews of Adhesion and Adhesives. 2014;2:467\u2013502. https:\/\/doi.org\/10.7569\/RAA.2014.097310.","journal-title":"Reviews of Adhesion and Adhesives."},{"key":"3531_CR184","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s10384-012-0228-2","volume":"57","author":"P Arg\u00fceso","year":"2013","unstructured":"Arg\u00fceso P. Glycobiology of the ocular surface: mucins and lectins. Jpn J Ophthalmol. 2013;57:150\u20135. https:\/\/doi.org\/10.1007\/s10384-012-0228-2.","journal-title":"Jpn J Ophthalmol"},{"key":"3531_CR185","doi-asserted-by":"publisher","unstructured":"P\u0131nar SG, Oktay AN, Karak\u00fc\u00e7\u00fck AE, \u00c7elebi N. Formulation Strategies of Nanosuspensions for Various Administration Routes. Pharmaceutics. Multidisciplinary Digital Publishing Institute; 2023;15:1520. https:\/\/doi.org\/10.3390\/pharmaceutics15051520","DOI":"10.3390\/pharmaceutics15051520"},{"key":"3531_CR186","doi-asserted-by":"publisher","unstructured":"Desai V, Ashok PA, Kulkarni P, Ahmed KA, Raikar PK. Enhancing Drug Bioavailability Through Mucoadhesive Technologies: A Comprehensive Review of Delivery Systems. Biomedical Materials & Devices [Internet]. 2026 [cited 2026 June 25];4:2791\u2013809. https:\/\/doi.org\/10.1007\/s44174-025-00405-2","DOI":"10.1007\/s44174-025-00405-2"},{"key":"3531_CR187","doi-asserted-by":"publisher","unstructured":"Jacob S, Kather FS, Boddu SHS, Attimarad M, Nair AB. Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques. Pharmaceutics [Internet]. Multidisciplinary Digital Publishing Institute; 2025 [cited 2026 June 25];17:136. https:\/\/doi.org\/10.3390\/pharmaceutics17010136","DOI":"10.3390\/pharmaceutics17010136"},{"key":"3531_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114046","volume":"386","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Kuang L, Lu C, Vo S, Narimatsu A, Kong Z, et al. Naturally derived mucoadhesive nanosuspension for treatment of multiple staged ocular infections. J Control Release. 2025;386:114046. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114046.","journal-title":"J Control Release"},{"key":"3531_CR189","doi-asserted-by":"publisher","unstructured":"Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudragit RS100\u00ae nanosuspensions for the ophthalmic controlled delivery of ibuprofen. European Journal of Pharmaceutical Sciences [Internet]. 2002 [cited 2026 June 25];16:53\u201361. https:\/\/doi.org\/10.1016\/S0928-0987(02)00057-X","DOI":"10.1016\/S0928-0987(02)00057-X"},{"key":"3531_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10238","volume":"6","author":"A Josyula","year":"2021","unstructured":"Josyula A, Omiadze R, Parikh K, Kanvinde P, Appell MB, Patel P, et al. An ion-paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection. Bioengineering & Translational Medicine. 2021;6:e10238. https:\/\/doi.org\/10.1002\/btm2.10238.","journal-title":"Bioengineering & Translational Medicine."},{"key":"3531_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/nano13040681","volume":"13","author":"M Alkholief","year":"2023","unstructured":"Alkholief M, Kalam MA, Alshememry AK, Ali R, Alhudaithi SS, Alsaleh NB, et al. Topical application of linezolid\u2013loaded chitosan nanoparticles for the treatment of eye infections. Nanomaterials. 2023;13:681. https:\/\/doi.org\/10.3390\/nano13040681.","journal-title":"Nanomaterials"},{"key":"3531_CR192","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13346-015-0262-y","volume":"6","author":"NP Ambhore","year":"2016","unstructured":"Ambhore NP, Dandagi PM, Gadad AP. Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery. Drug Deliv and Transl Res. 2016;6:48\u201356. https:\/\/doi.org\/10.1007\/s13346-015-0262-y.","journal-title":"Drug Deliv and Transl Res."},{"key":"3531_CR193","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12247-015-9224-7","volume":"10","author":"AA Abdelrahman","year":"2015","unstructured":"Abdelrahman AA, Salem HF, Khallaf RA, Ali AMA. Modeling, Optimization, and In Vitro Corneal Permeation of Chitosan-Lomefloxacin HCl Nanosuspension Intended for Ophthalmic Delivery. J Pharm Innov. 2015;10:254\u201368. https:\/\/doi.org\/10.1007\/s12247-015-9224-7.","journal-title":"J Pharm Innov."},{"key":"3531_CR194","doi-asserted-by":"publisher","unstructured":"Elhabal SF, Faheem AM, Hababeh S, Nelson J, Elzohairy NA, AbdelGhany Morsy SA, et al. Dissolving Microneedles Containing Lactoferrin Nanosuspension for Enhancement of Antimicrobial and Anti-Inflammatory Effects in the Treatment of Dry Eye Disease. Pharmaceutics [Internet]. 2025 [cited 2026 Mar 21];17:653. https:\/\/doi.org\/10.3390\/pharmaceutics17050653","DOI":"10.3390\/pharmaceutics17050653"},{"key":"3531_CR195","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1007\/s13346-022-01155-0","volume":"12","author":"P Khare","year":"2022","unstructured":"Khare P, Chogale MM, Kakade P, Patravale VB. Gellan gum\u2013based in situ gelling ophthalmic nanosuspension of Posaconazole. Drug Deliv and Transl Res. 2022;12:2920\u201335. https:\/\/doi.org\/10.1007\/s13346-022-01155-0.","journal-title":"Drug Deliv and Transl Res."},{"key":"3531_CR196","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijpharm.2012.11.044","volume":"443","author":"AM Cerdeira","year":"2013","unstructured":"Cerdeira AM, Mazzotti M, Gander B. Formulation and drying of miconazole and itraconazole nanosuspensions. International Journal of Pharmaceutics. 2013;443:209\u201320. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.11.044.","journal-title":"International Journal of Pharmaceutics."},{"key":"3531_CR197","doi-asserted-by":"publisher","unstructured":"Ahuja M, Verma P, Bhatia M. Preparation and evaluation of chitosan\u2013itraconazole co-precipitated nanosuspension for ocular delivery. Journal of Experimental Nanoscience. Taylor & Francis; 2015;10:209\u201321. https:\/\/doi.org\/10.1080\/17458080.2013.822108","DOI":"10.1080\/17458080.2013.822108"},{"key":"3531_CR198","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17030332","volume":"17","author":"J Li","year":"2025","unstructured":"Li J, Ma P, Guo S, Qin D, Wang Y, Liu Y, et al. Evaluation of nano-niclosamide in killing Demodex folliculorum in vitro and the potential application in ocular surface. Pharmaceutics. 2025;17:332. https:\/\/doi.org\/10.3390\/pharmaceutics17030332.","journal-title":"Pharmaceutics"},{"key":"3531_CR199","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s13346-021-00966-x","volume":"11","author":"W Fan","year":"2021","unstructured":"Fan W, Han H, Chen Y, Zhang X, Gao Y, Li S, et al. Antimicrobial nanomedicine for ocular bacterial and fungal infection. Drug Deliv Transl Res. 2021;11:1352\u201375. https:\/\/doi.org\/10.1007\/s13346-021-00966-x.","journal-title":"Drug Deliv Transl Res."},{"key":"3531_CR200","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1039\/d3bm00505d","volume":"11","author":"Y Su","year":"2023","unstructured":"Su Y, Fan X, Pang Y. Nano-based ocular drug delivery systems: an insight into the preclinical\/clinical studies and their potential in the treatment of posterior ocular diseases. Biomater Sci. 2023;11:4490\u2013507. https:\/\/doi.org\/10.1039\/d3bm00505d.","journal-title":"Biomater Sci."},{"key":"3531_CR201","doi-asserted-by":"publisher","unstructured":"Wang T, Wang Y, Li S, Wang Y, Lan X. Nanomedicine in ophthalmology: conquering anatomical barriers and enhancing therapeutic efficacy. Biomater Sci [Internet]. The Royal Society of Chemistry; 2026 [cited 2026 Mar 21];14:611\u201331. https:\/\/doi.org\/10.1039\/D5BM00325C","DOI":"10.1039\/D5BM00325C"},{"key":"3531_CR202","unstructured":"Shire. A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis [Internet]. clinicaltrials.gov; 2021 May. Report No.: NCT02998541. https:\/\/clinicaltrials.gov\/study\/NCT02998541. Accessed 21 Mar 2026"},{"key":"3531_CR203","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40005-020-00474-z","volume":"50","author":"P Jansook","year":"2020","unstructured":"Jansook P, Maw PD, Soe HMSH, Chuangchunsong R, Saiborisuth K, Payonitikarn N, et al. Development of amphotericin B nanosuspensions for fungal keratitis therapy: effect of self-assembled \u03b3-cyclodextrin. J Pharm Investig. 2020;50:513\u201325. https:\/\/doi.org\/10.1007\/s40005-020-00474-z.","journal-title":"J Pharm Investig"},{"key":"3531_CR204","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10238","volume":"6","author":"A Josyula","year":"2021","unstructured":"Josyula A, Omiadze R, Parikh K, Kanvinde P, Appell MB, Patel P, et al. An ion-paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection. Bioeng Transl Med. 2021;6:e10238. https:\/\/doi.org\/10.1002\/btm2.10238.","journal-title":"Bioeng Transl Med."},{"key":"3531_CR205","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.2147\/IJN.S348822","volume":"17","author":"Y Mao","year":"2022","unstructured":"Mao Y, Chen Y, Liu C, He X, Zheng Y, Chen X, et al. Cefquinome Sulfate Oily Nanosuspension Designed for Improving its Bioavailability in the Treatment of Veterinary Infections. Int J Nanomedicine. 2022;17:2535\u201353. https:\/\/doi.org\/10.2147\/IJN.S348822.","journal-title":"Int J Nanomedicine."},{"key":"3531_CR206","doi-asserted-by":"publisher","unstructured":"Yan R, Xu L, Wang Q, Wu Z, Zhang H, Gan L. Cyclosporine A Nanosuspensions for Ophthalmic Delivery: A Comparative Study between Cationic Nanoparticles and Drug-Core Mucus Penetrating Nanoparticles. Mol Pharmaceutics [Internet]. American Chemical Society; 2021 [cited 2026 Mar 21];18:4290\u20138. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00370","DOI":"10.1021\/acs.molpharmaceut.1c00370"},{"key":"3531_CR207","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/pharmaceutics13101586","volume":"13","author":"N Wang","year":"2021","unstructured":"Wang N, Qi F, He X, Shi H, Anderson DW, Li H, et al. Preparation and Pharmacokinetic Characterization of an Anti-Virulence Compound Nanosuspensions. Pharmaceutics. 2021;13:1586. https:\/\/doi.org\/10.3390\/pharmaceutics13101586.","journal-title":"Pharmaceutics."},{"key":"3531_CR208","doi-asserted-by":"publisher","unstructured":"Sakhare S, Shinde SD, Venkatrao Yadav A, Somnath Shete A. Studies on Formulation and Evaluation of Eudragit RS PO Based Nanoparticulate System of Aceclofenac for Ocular Delivery. IJPER [Internet]. 2021 [cited 2026 Mar 22];55:s87\u201399. https:\/\/doi.org\/10.5530\/ijper.55.1s.40","DOI":"10.5530\/ijper.55.1s.40"},{"key":"3531_CR209","doi-asserted-by":"publisher","unstructured":"Morteza-Semnani K, Saeedi M, Akbari J, Moazeni M, Seraj H, Daftarifard E, et al. Fluconazole Nanosuspension Enhances In Vitro Antifungal Activity against Resistant Strains of Candida albicans. Pharm Sci [Internet]. Tabriz University of Medical Sciences; 2021 [cited 2026 Mar 22];28:112\u201329. https:\/\/doi.org\/10.34172\/PS.2021.21","DOI":"10.34172\/PS.2021.21"},{"key":"3531_CR210","doi-asserted-by":"publisher","unstructured":"Khare P, Chogale MM, Kakade P, Patravale VB. Gellan gum\u2013based in situ gelling ophthalmic nanosuspension of Posaconazole. Drug Deliv Transl Res [Internet]. 2022 [cited 2026 Mar 13];12:2920\u201335. https:\/\/doi.org\/10.1007\/s13346-022-01155-0","DOI":"10.1007\/s13346-022-01155-0"},{"key":"3531_CR212","doi-asserted-by":"publisher","unstructured":"Peter S, Mathews MM, Saju F, Paul S. Development, Optimization and In Vitro Characterization of Eudragit-Ganciclovir Nanosuspension or Treating Herpes Simplex Keratitis. J Pharm Innov [Internet]. 2023 [cited 2026 Mar 22];18:1328\u201337. https:\/\/doi.org\/10.1007\/s12247-023-09723-8","DOI":"10.1007\/s12247-023-09723-8"},{"key":"3531_CR213","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s13346-025-02021-5","volume":"16","author":"BHJ Gowda","year":"2026","unstructured":"Gowda BHJ, Pandya AK, Gade S, Duncan R, Paredes AJ, Ahmed MG, et al. Voriconazole nanosuspension-loaded ocular bilayer dissolving microneedle patch for the management of fungal keratitis. Drug Deliv Transl Res. 2026;16:1164\u201387. https:\/\/doi.org\/10.1007\/s13346-025-02021-5.","journal-title":"Drug Deliv Transl Res."},{"key":"3531_CR214","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145356","volume":"319","author":"B Li","year":"2025","unstructured":"Li B, Shemkai JC, Zhang Q, Qiao F, Yu N, Zhao J, et al. Fabrication of an alginate-poloxamer 407 thermosensitive carboxymethyl chitosan stabilized nanosuspension hydrogel for enhanced ocular delivery of clobetasol propionate in uveitis management. Int J Biol Macromol. 2025;319:145356. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145356.","journal-title":"Int J Biol Macromol."},{"key":"3531_CR215","doi-asserted-by":"publisher","first-page":"16149","DOI":"10.2147\/IJN.S562002","volume":"20","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Chen J, Zhang H, Yu W, Xu H, Wang Q, et al. Enhanced Everolimus Delivery: Development and Evaluation of a Nanosuspension Formulation. Int J Nanomedicine. 2025;20:16149\u201365. https:\/\/doi.org\/10.2147\/IJN.S562002.","journal-title":"Int J Nanomedicine."},{"key":"3531_CR216","doi-asserted-by":"publisher","unstructured":"Zheng Y, Kuang L, Lu C, Vo S, Narimatsu A, Kong Z, et al. Naturally derived mucoadhesive nanosuspension for treatment of multiple staged ocular infections. Journal of Controlled Release [Internet]. 2025 [cited 2026 Mar 22];386:114046. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114046","DOI":"10.1016\/j.jconrel.2025.114046"},{"key":"3531_CR217","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1007\/s00289-023-05113-9","volume":"81","author":"E Hajirasouliha","year":"2024","unstructured":"Hajirasouliha E, Zandi M, Hashemi Tabatabaei M, Zarrinbakhsh P. Ocular contact lenses: smart materials for biomedical applications. Polym Bull. 2024;81:7791\u2013832. https:\/\/doi.org\/10.1007\/s00289-023-05113-9.","journal-title":"Polym Bull"},{"key":"3531_CR218","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1021\/acsinfecdis.8b00030","volume":"4","author":"A Goes","year":"2018","unstructured":"Goes A, Fuhrmann G. Biogenic and biomimetic carriers as versatile transporters to treat infections. ACS Infect Dis. 2018;4:881\u201392. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00030.","journal-title":"ACS Infect Dis"},{"key":"3531_CR219","doi-asserted-by":"publisher","unstructured":"Chen X, Yang R, Shen J, Huang Q, Wu Z. Research Progress of Bioinspired Nanostructured Systems for the Treatment of Ocular Disorders. Pharmaceuticals (Basel) [Internet]. 2023 [cited 2026 Mar 21];16:96. https:\/\/doi.org\/10.3390\/ph16010096","DOI":"10.3390\/ph16010096"},{"key":"3531_CR220","doi-asserted-by":"publisher","unstructured":"Trousil J, Aryal S, Fuhrmann G. Biogenic and Biomimetic Nanocarrier-Based Interventions: Focus on Intracellular Infections. Nanomedicine (Lond) [Internet]. 2021 [cited 2026 Mar 21];16:685\u20138. https:\/\/doi.org\/10.2217\/nnm-2021-0052","DOI":"10.2217\/nnm-2021-0052"},{"key":"3531_CR221","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/IIO.0000000000000562","volume":"65","author":"N Shekhawat","year":"2025","unstructured":"Shekhawat N. Precision medicine for diagnosis of microbial keratitis. Int Ophthalmol Clin. 2025;65:20\u20135. https:\/\/doi.org\/10.1097\/IIO.0000000000000562.","journal-title":"Int Ophthalmol Clin"},{"key":"3531_CR222","doi-asserted-by":"publisher","unstructured":"Zhang T, Luo Z. Stimulus-responsive nanomaterials for ocular antimicrobial therapy. Nanoscale [Internet]. The Royal Society of Chemistry; 2025 [cited 2026 Mar 21];17:13653\u201367. https:\/\/doi.org\/10.1039\/D4NR05462H","DOI":"10.1039\/D4NR05462H"},{"key":"3531_CR223","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1021\/acsnano.2c03971","volume":"16","author":"K Zhu","year":"2022","unstructured":"Zhu K, Qian S, Guo H, Wang Q, Chu X, Wang X, et al. pH-activatable organic nanoparticles for efficient low-temperature photothermal therapy of ocular bacterial infection. ACS Nano. 2022;16:11136\u201351. https:\/\/doi.org\/10.1021\/acsnano.2c03971.","journal-title":"ACS Nano"},{"key":"3531_CR224","doi-asserted-by":"publisher","unstructured":"Naik JB, Pardeshi SR, Patil RP, Patil PB, Mujumdar A. Mucoadhesive Micro-\/Nano Carriers in Ophthalmic Drug Delivery: an Overview. BioNanoSci [Internet]. 2020 [cited 2026 Mar 21];10:564\u201382. https:\/\/doi.org\/10.1007\/s12668-020-00752-y","DOI":"10.1007\/s12668-020-00752-y"},{"key":"3531_CR225","doi-asserted-by":"publisher","DOI":"10.3390\/polym12071519","volume":"12","author":"A Zamboulis","year":"2020","unstructured":"Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali NM, et al. Chitosan and its derivatives for ocular delivery formulations: recent advances and developments. Polymers (Basel). 2020;12:1519. https:\/\/doi.org\/10.3390\/polym12071519.","journal-title":"Polymers (Basel)"},{"key":"3531_CR226","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/pharmaceutics16121604","volume":"16","author":"M Kim","year":"2024","unstructured":"Kim M, Jung M-Y, Lee D-Y, Ahn SM, Lee GM, Park CY. How to Fabricate Hyaluronic Acid for Ocular Drug Delivery. Pharmaceutics. 2024;16:1604. https:\/\/doi.org\/10.3390\/pharmaceutics16121604.","journal-title":"Pharmaceutics."},{"key":"3531_CR227","doi-asserted-by":"publisher","unstructured":"Liu J, Jiang F, Jiang Y, Wang Y, Li Z, Shi X, et al. Roles of Exosomes in Ocular Diseases. Int J Nanomedicine [Internet]. 2020 [cited 2026 Mar 21];15:10519\u201338. https:\/\/doi.org\/10.2147\/IJN.S277190","DOI":"10.2147\/IJN.S277190"},{"key":"3531_CR228","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13287-022-02854-8","volume":"13","author":"S Ma","year":"2022","unstructured":"Ma S, Liu X, Yin J, Hao L, Diao Y, Zhong J. Exosomes and autophagy in ocular surface and retinal diseases: new insights into pathophysiology and treatment. Stem Cell Res Ther. 2022;13:174. https:\/\/doi.org\/10.1186\/s13287-022-02854-8.","journal-title":"Stem Cell Res Ther"},{"key":"3531_CR229","doi-asserted-by":"publisher","unstructured":"Extracellular vesicles for ophthalmic and dermal ailments. Extracellular Vesicles for Therapeutic and Diagnostic Applications [Internet]. Elsevier; 2025 [cited 2026 Mar 21]. p. 283\u2013345. https:\/\/doi.org\/10.1016\/B978-0-443-23891-8.00011-1","DOI":"10.1016\/B978-0-443-23891-8.00011-1"},{"key":"3531_CR230","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrd2659","volume":"7","author":"ME Hemler","year":"2008","unstructured":"Hemler ME. Targeting of tetraspanin proteins\u2013potential benefits and strategies. Nat Rev Drug Discov. 2008;7:747\u201358. https:\/\/doi.org\/10.1038\/nrd2659.","journal-title":"Nat Rev Drug Discov."},{"key":"3531_CR231","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400664","volume":"20","author":"K Xu","year":"2025","unstructured":"Xu K, Feng H, Zhao R, Huang Y. Targeting tetraspanins at cell interfaces: functional modulation and exosome-based drug delivery for precise disease treatment. ChemMedChem. 2025;20:e202400664. https:\/\/doi.org\/10.1002\/cmdc.202400664.","journal-title":"ChemMedChem"},{"key":"3531_CR232","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-12-805417-8.00014-7","volume-title":"Immunity and inflammation in health and disease","author":"AK Schaefer","year":"2017","unstructured":"Schaefer AK, Melnyk JE, He Z, Del Rosario F, Grimes CL. Pathogen- and microbial- associated molecular patterns (PAMPs\/MAMPs) and the innate immune response in Crohn\u2019s disease. In: Immunity and inflammation in health and disease. Elsevier; 2017. p. 175\u201387. https:\/\/doi.org\/10.1016\/B978-0-12-805417-8.00014-7."},{"key":"3531_CR233","volume-title":"Veterinary ophthalmology","author":"KN Gelatt","year":"2021","unstructured":"Gelatt KN, Ben-Shlomo G, Gilger BC, Hendrix DVH, Kern TJ, Plummer CE. Veterinary ophthalmology. John Wiley & Sons; 2021."},{"key":"3531_CR234","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41427-025-00614-7","volume":"17","author":"J Lee","year":"2025","unstructured":"Lee J, Jeong J, Nguyen VP, Hong S, Paulus YM, Lee CH. Microneedles for controlled and sustained intraocular drug delivery. NPG Asia Mater. 2025;17:33. https:\/\/doi.org\/10.1038\/s41427-025-00614-7.","journal-title":"NPG Asia Mater."},{"key":"3531_CR235","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061746","volume":"15","author":"M Mostafa","year":"2023","unstructured":"Mostafa M, Al Fatease A, Alany RG, Abdelkader H. Recent advances of ocular drug delivery systems: prominence of ocular implants for chronic eye diseases. Pharmaceutics. 2023;15:1746. https:\/\/doi.org\/10.3390\/pharmaceutics15061746.","journal-title":"Pharmaceutics"},{"key":"3531_CR236","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1186\/s12903-023-03746-w","volume":"23","author":"YA Tahmawy","year":"2023","unstructured":"Tahmawy YA, Mohamed FS, Elfeki S, Abd-Ellah ME. Microbiological evaluation of conjunctival anopthalmic flora after using digital 3D-printed ocular prosthesis compared to conventional one: a randomized clinical trial. BMC Oral Health. 2023;23:1012. https:\/\/doi.org\/10.1186\/s12903-023-03746-w.","journal-title":"BMC Oral Health."},{"key":"3531_CR237","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/pharmaceutics15010243","volume":"15","author":"F Annuryanti","year":"2023","unstructured":"Annuryanti F, Dom\u00ednguez-Robles J, Anjani QK, Adrianto MF, Larra\u00f1eta E, Thakur RRS. Fabrication and Characterisation of 3D-Printed Triamcinolone Acetonide-Loaded Polycaprolactone-Based Ocular Implants. Pharmaceutics. 2023;15:243. https:\/\/doi.org\/10.3390\/pharmaceutics15010243.","journal-title":"Pharmaceutics."},{"key":"3531_CR238","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.2147\/IJN.S375570","volume":"17","author":"C Zhang","year":"2022","unstructured":"Zhang C, Yin Y, Zhao J, Li Y, Wang Y, Zhang Z, et al. An update on novel ocular nanosystems with possible benefits in the treatment of corneal neovascularization. Int J Nanomedicine. 2022;17:4911\u201331. https:\/\/doi.org\/10.2147\/IJN.S375570.","journal-title":"Int J Nanomedicine"},{"key":"3531_CR239","doi-asserted-by":"publisher","unstructured":"Zieli\u0144ska A, Soles BB, Lopes AR, Vaz BF, Rodrigues CM, Alves TFR, et al. Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications. Biology [Internet]. Multidisciplinary Digital Publishing Institute; 2020 [cited 2026 June 25];9:336. https:\/\/doi.org\/10.3390\/biology9100336","DOI":"10.3390\/biology9100336"},{"key":"3531_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/gels8020082","volume":"8","author":"MH Akhter","year":"2022","unstructured":"Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, et al. Drug delivery challenges and current progress in nanocarrier-based ocular therapeutic system. Gels. 2022;8:82. https:\/\/doi.org\/10.3390\/gels8020082.","journal-title":"Gels"},{"key":"3531_CR241","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010136","volume":"17","author":"S Jacob","year":"2025","unstructured":"Jacob S, Kather FS, Boddu SHS, Attimarad M, Nair AB. Nanosuspension innovations: expanding horizons in drug delivery techniques. Pharmaceutics. 2025;17:136. https:\/\/doi.org\/10.3390\/pharmaceutics17010136.","journal-title":"Pharmaceutics"},{"key":"3531_CR242","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/pharmaceutics16101325","volume":"16","author":"BR Giri","year":"2024","unstructured":"Giri BR, Jakka D, Sandoval MA, Kulkarni VR, Bao Q. Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics. 2024;16:1325. https:\/\/doi.org\/10.3390\/pharmaceutics16101325.","journal-title":"Pharmaceutics."},{"key":"3531_CR243","doi-asserted-by":"publisher","unstructured":"Ali Y, Lehmussaari K. Industrial perspective in ocular drug delivery. Advanced Drug Delivery Reviews [Internet]. 2006 [cited 2026 June 25];58:1258\u201368. https:\/\/doi.org\/10.1016\/j.addr.2006.07.022","DOI":"10.1016\/j.addr.2006.07.022"},{"key":"3531_CR244","unstructured":"Research C for DE and. Quality Considerations for Topical Ophthalmic Drug Products [Internet]. FDA; 2023 [cited 2026 June 26]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/quality-considerations-topical-ophthalmic-drug-products. Accessed 26 June 2026"},{"key":"3531_CR245","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1208\/s12248-016-9932-z","volume":"18","author":"SH Choi","year":"2016","unstructured":"Choi SH, Lionberger RA. Clinical, Pharmacokinetic, and In Vitro Studies to Support Bioequivalence of Ophthalmic Drug Products. AAPS J. 2016;18:1032\u20138. https:\/\/doi.org\/10.1208\/s12248-016-9932-z.","journal-title":"AAPS J."},{"key":"3531_CR246","doi-asserted-by":"publisher","unstructured":"Zhang C, Yin Y, Zhao J, Li Y, Wang Y, Zhang Z, et al. An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization. Int J Nanomedicine [Internet]. 2022 [cited 2026 June 24];17:4911\u201331. https:\/\/doi.org\/10.2147\/IJN.S375570","DOI":"10.2147\/IJN.S375570"},{"key":"3531_CR247","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/jop.2012.0241","volume":"29","author":"SA Molokhia","year":"2013","unstructured":"Molokhia SA, Thomas SC, Garff KJ, Mandell KJ, Wirostko BM. Anterior eye segment drug delivery systems: current treatments and future challenges. J Ocul Pharmacol Ther. 2013;29:92\u2013105. https:\/\/doi.org\/10.1089\/jop.2012.0241.","journal-title":"J Ocul Pharmacol Ther."},{"key":"3531_CR248","doi-asserted-by":"publisher","unstructured":"Luke MC, Kozak D. Regulating Generic Ophthalmologic Drug Bioequivalence\u2014Envisioning Accessibility for Patients. Journal of Ocular Pharmacology and Therapeutics [Internet]. SAGE Publications; 2021 [cited 2026 June 24];37:157\u201361. https:\/\/doi.org\/10.1089\/jop.2020.0041","DOI":"10.1089\/jop.2020.0041"},{"key":"3531_CR249","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1208\/s12249-025-03159-8","volume":"26","author":"S Sultana","year":"2025","unstructured":"Sultana S, Yusuf M, Sharma V. Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions. AAPS PharmSciTech. 2025;26:197. https:\/\/doi.org\/10.1208\/s12249-025-03159-8.","journal-title":"AAPS PharmSciTech."},{"key":"3531_CR250","unstructured":"U.S. Food and Drug Administration. Draft Guidance on Loteprednol Etabonate Ophthalmic Suspension_Drops [Internet]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_020803.pdf. Accessed 24 June 2026"},{"key":"3531_CR251","unstructured":"U.S. Food and Drug Administration. Draft Guidance on Prednisolone Acetate Oral Suspension [Internet]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/psg\/PSG_022067.pdf. Accessed 24 June 2026"},{"key":"3531_CR252","unstructured":"U.S. Food and Drug Administration. Draft Guidance on Vexol (rimexolone ophthalmic suspension) 1%."},{"key":"3531_CR253","doi-asserted-by":"publisher","unstructured":"Wei J, Mu J, Tang Y, Qin D, Duan J, Wu A. Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy. J Nanobiotechnology [Internet]. 2023 [cited 2026 Mar 21];21:282. https:\/\/doi.org\/10.1186\/s12951-023-01974-4","DOI":"10.1186\/s12951-023-01974-4"},{"key":"3531_CR254","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1208\/s12248-017-0128-y","volume":"19","author":"E Wakshull","year":"2017","unstructured":"Wakshull E, Quarmby V, Mahler H-C, Rivers H, Jere D, Ramos M, et al. Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space. AAPS J. 2017;19:1656\u201368. https:\/\/doi.org\/10.1208\/s12248-017-0128-y.","journal-title":"AAPS J."},{"key":"3531_CR255","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3109\/17435390.2016.1153165","volume":"10","author":"NK Mehra","year":"2016","unstructured":"Mehra NK, Cai D, Kuo L, Hein T, Palakurthi S. Safety and toxicity of nanomaterials for ocular drug delivery applications. Nanotoxicology. 2016;10:836\u201360. https:\/\/doi.org\/10.3109\/17435390.2016.1153165.","journal-title":"Nanotoxicology"},{"key":"3531_CR256","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/17425247.2024.2311119","volume":"21","author":"F Geng","year":"2024","unstructured":"Geng F, Fan X, Liu Y, Lu W, Wei G. Recent advances in nanocrystal-based technologies applied for ocular drug delivery. Expert Opin Drug Deliv. 2024;21:211\u201327. https:\/\/doi.org\/10.1080\/17425247.2024.2311119.","journal-title":"Expert Opin Drug Deliv"},{"key":"3531_CR257","doi-asserted-by":"publisher","unstructured":"Shahror RA, Fouda AY. Recent advances and future challenges in nanosystems for ocular drug delivery. J Pharmacol Exp Ther [Internet]. 2025 [cited 2026 June 24];392:103738. https:\/\/doi.org\/10.1016\/j.jpet.2025.103738","DOI":"10.1016\/j.jpet.2025.103738"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03531-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:47:15Z","timestamp":1788976035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03531-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":256,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3531"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03531-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"278"}}